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“Messieurs, ce sont les microbes qui auront le dernier mot!” 
 
 LOUIS PASTEUR 
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Este trabajo se ha basado en investigaciones previas de nuestro grupo sobre el operón 
opvAB de Salmonella enterica y ha utilizado dichos conocimientos para diseñar y 
desarrollar tres aplicaciones biotecnológicas: (i) la formación de subpoblaciones 
bacterianas que difieran en un fenotipo específico elegido a voluntad, (ii) el desarrollo 
de un biosensor capaz de detectar bacteriófagos, y (iii) la detección de inhibidores de la 
metilación del DNA. 
 
(i) Estudios previos habían establecido que la transcripción del operón opvAB 
está sujeta a biestabilidad reversible (cambio de fase). Este trabajo describe 
que la clonación de un fragmento de 689 pares de bases que contiene el 
promotor y la región reguladora (UAS) de opvAB es capaz de conferir 
biestabilidad reversible a genes heterólogos (ej., el operón lac y diversos 
genes de resistencia a antibióticos). El sistema de cambio de fase es 
exportable a Escherichia coli. La expresión de genes de resistencia a 
antibióticos bajo el control de opvAB genera subpoblaciones resistentes y 
sensibles al antibiótico en cuestión, y puede ser útil para el estudio de la 
heteroresistencia a antibióticos. La heteroresistencia es un fenómeno de gran 
relevancia clínica ya que la aparición de subpoblaciones resistentes es difícil 
de detectar y con frecuencia causa un fallo en el tratamiento de las 
infecciones.  
 
(ii) Los productos del operón opvAB son proteínas que acortan el antígeno O del 
lipopolisacárido, generando resistencia a bacteriófagos que usan el antígeno 
O como receptor. Esta propiedad ha permitido desarrollar biosensores para la 
detección de bacteriófagos. Dichos sensores se basan en la detección de 
fluorescencia emitida por la proteína verde fluorescente, GFP, y han sido 
generados por manipulación genética de la estirpe silvestre. Además de ser 
una alternativa al uso de los antibióticos, los bacteriófagos tienen 
importancia en ecología ya que participan activamente en el control de las 
comunidades bacterianas y en la transferencia de información genética entre 
bacterias. 
 
(iii) La transcripción del operón opvAB está regulada por metilación Dam, y la 
ausencia de metilación Dam origina expresión constitutiva. En una estirpe 
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que produce proteína verde fluorescente (GFP) bajo el control de opvAB, la 
inhibición de la metilación Dam se puede detectar como un aumento de 
fluorescencia. La funcionalidad de este sistema de detección se ha 
demostrado en presencia concentraciones muy bajas de sinefungina, un 
inhibidor comercial de la metilación del DNA. Esta prueba de concepto 
sugiere que el sensor puede ser útil en la búsqueda de nuevos inhibidores de 
la metilasa Dam, potencialmente útiles como fármacos antibacterianos.  
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The genus Salmonella 
The genus Salmonella belongs to the family Enterobacteriaceae, which is classified in 
the 𝛾-proteobacteria subdivision. Salmonella is phylogenetically close to the genera 
Escherichia, Shigella, and Citrobacter. The genus Salmonella includes facultative 
anaerobic, rod-shaped Gram-negative bacteria. Most Salmonellae are motile and are 
able to infect a wide variety of animal hosts including amphibians, reptiles, mammals, 
and birds. Current taxonomy divides the genus Salmonella into two species, Salmonella 
enterica and Salmonella bongori [1]. In turn, Salmonella enterica includes six 
subspecies [2]: enterica (I), salamae (II), arizonae (IIIa), diarizonae (IIIb), houtenae 
(IV) and indica (VI). 
 
Salmonella isolates from the same subspecies are further classified into serovars based 
on the White-Kauffman classification scheme [3], which relies on specific patterns of 
agglutination reactions based on antisera against two highly variable surface antigens, O 
(lipopolysaccharide O-antigen) and H (flagellar proteins) [2], [4]. There are more than 
2,500 Salmonella serovars, most of which belong to subsp. enterica [3]. Only serovars 
of this subspecies regularly colonize warm-blooded vertebrates [5], and so they account 
for 99% of human infections by Salmonella, while serovars of Salmonella bongori and 
other Salmonella enterica subspecies are usually associated to cold-blooded vertebrates 
or found in the environment [6]. 
 
 Serovars belonging to subsp. enterica differ in their host specificity and in the types of 
diseases they promote. Some serovars are host-restricted, while others can infect a wide 
variety of animal hosts [7, p. 2]. The diseases caused by subsp. enterica serovars vary 
from self-limiting gastroenteritis to life-threatening systemic infection, and the outcome 
of the disease depends on the specific serovar-host combination. An example of 
specialist is S. Typhi, the causing agent of typhoid fever. In contrast, S. Typhimurium 
produces mild gastroenteritis in humans but causes a systemic infection similar to 
human typhoid fever when infecting immunodeficient mice [8]. 
S. Typhi causes more than 27 millions of cases of typhoid fever worldwide, with 
217,000 deaths approximately [9], whereas S. Typhimurium and S. Enteritidis cause 
>90 million infections worldwide with more than 150,000 deaths per year [10]. In sub-
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Saharian Africa, S. Typhimurium and S. Enteriditis cause high rates of bacteremia in 
immunocompromised patients and in children [11],  [12].  
 
The interaction between serovar Typhimurium and mice has been extensively used as a 
model for typhoid fever in humans [13]. A widely used mouse-virulent strain is ATCC 
14028 [14]. 
 
Evolution of Salmonella 
 Salmonella and Escherichia are close relatives, and diverged 120-160 million years ago 
[15]. Almost 25% of the Salmonella genome consists of genetic material that is absent 
in Escherichia coli [5], [16]. The evolution of Salmonella pathogenicity (Figure I.1) 
has involved sequential acquisition of genetic elements, each contributing to different 
aspects of its lifestyle [17], [18]. Amongst those elements are the Salmonella 
pathogenicity islands (SPIs), which are clusters of virulence genes located in the 
chromosome. More than 10 SPIs have been described [19], including some which are 
serotype-specific. These regions are absent in the chromosome of other 
Enterobacteriaceae, and usually have different G+C content than the average of the 
Salmonella chromosome, suggesting that they have been acquired by horizontal gene 
transfer [16], [18].  
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Figure I.1. Phylogeny of the genus Salmonella. Modified from [20].  
 
The best characterized SPIs are Salmonella pathogenicity islands 1 (SPI-1) and 2 (SPI-
2). SPI-1 was acquired first by the common ancestor of the two Salmonella species, and 
is involved in the invasion of intestinal epithelial cells in the animal host [21]. SPI-1 
acquisition likely allowed Salmonella to become an intracellular pathogen associated 
with cold-blooded vertebrates [20]. 
 
 SPI-2 allows Salmonella to survive in macrophages and colonize deep tissues [22], and 
its acquisition marked the split of the two Salmonella species [20]. Hence, only 
members of Salmonella enterica have the ability to reach deep tissues and organs to 
produce systemic infections. The ancestor of subsp. enterica acquired the capacity to 
infect warm-blooded vertebrates, and different lineages subsequently evolved to 
colonize a variety of hosts. Even though the mechanisms of host specificity are not fully 
understood, the presence of a virulence plasmid in some serovars of subsp. enterica has 
suggested the potential involvement of plasmid functions [6]. Another factor that may 
be involved in host specificity is the presence of different sets of fimbrial operons in 
different serovars [6], [23]. 
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Salmonella infection 
Infection with Salmonella enterica is usually caused by ingestion of contaminated food 
or water. Along the digestive track, Salmonella must endure adverse conditions that 
serve as protective mechanisms against bacterial infections. In the stomach, acid pH 
destroys the majority of microorganisms [24]. Activation of the acid tolerance response 
enables Salmonella to endure periods of severe acid stress [25], [26]. In the small 
intestine, Salmonella finds high concentrations of bile, secreted in the duodenum during 
digestion. Bile has two main antibacterial activities: as a detergent that disrupts the cell 
envelope [27] and as a DNA damaging agent [28]. However, Salmonella and other 
enterobacteria are intrinsically resistant to high concentrations of bile [27]. Bile 
resistance is a complex phenomenon and involves multiple mechanisms including 
formation of physical barriers such as the lipopolysaccharide [29] and the 
enterobacterial common antigen [30], active efflux [31], [32], activation of the general 
stress response [33] and modification of the peptidoglycan structure [34]. 
 
 
Figure I2. Diagram of Salmonella infection. The three main routes of Salmonella invasion of the 
intestinal epithelium are represented: adhesion and translocation through M cells, direct invasion of 
intestinal epithelial cells, and capture by dendritic cells. Reproduced from [35]. 
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When Salmonella reaches the distal small intestine, adhesins and fimbriae allow the 
pathogen to adhere to the intestinal epithelium [36]. Salmonella is able to invade the 
intestinal epithelium through three different routes (Figure I2): (i) by inducing a 
phagocytosis-like process in non-phagocytic enterocytes, (ii) through specialized 
epithelial M cells, and (iii) through dendritic cells that intercalate epithelial cells by 
extending protrusions into the gut lumen [37], [38]. The two first routes are mediated by 
the virulence-associated type 3 secretion system encoded on Salmonella pathogenicity 
island 1 (SPI-1) [39], and invasion of M cells is the predominant route of intestinal 
traversal [40]. After invasion, and depending on the host-serovar combination, 
Salmonella can cause two main kinds of infection: gastroenteritis and systemic 
infection. In gastroenteritis, the infection is localized in the intestine, and induces an 
inflammatory reaction in the intestinal mucosa. Accumulation of liquid in the intestinal 
lumen leads to diarrhea [41], [42]. The inflammatory response creates a novel luminal 
niche, which favors growth of Salmonella over the resident microbiota of the intestine. 
Remarkably, the cascade of events that takes place as consequence of inflammation 
produces the accumulation of tetrathionate (S4O62-) in the intestinal lumen [43]. 
Salmonella can use tetrathionate as electron acceptor for respiration to obtain energy for 
growth in the inflamed gut lumen, taking advantage over the resident microbiota, which 
must rely on less efficient fermentation processes. In systemic infection, Salmonella 
crosses the epithelial barrier and can survive inside phagocytes due to the possession of 
a second type 3 secretion system encoded on Salmonella pathogenicity island 2 (SPI-2). 
Dissemination through the lymphatic system permits colonization of multiple target 
organs, particularly the spleen, the liver, the gall bladder and the bone marrow [44]. A 
fraction of individuals recovering from systemic infection become asymptomatic, life-
long carriers of Salmonella, acting as reservoirs for future infections. In humans, 
serovar Typhi can establish chronic carriage in the gall bladder [44].  
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Formation of bacterial lineages 
The study of differentiation in bacterial species that undergo developmental programs 
has played a historic role in biology [45]–[47]. In addition, phenotypic differences 
between colonies [48] and within colonies [49] were described many years ago in 
bacterial species that do not undergo development. Despite their technical limitations, 
these early studies contributed to bring about the idea that phenotypic heterogeneity 
might be a common phenomenon in the bacterial world [50]. This view has been 
confirmed by single cell analysis technologies [51]–[55]. Furthermore, theoretical 
analysis has provided evidence that phenotypic heterogeneity can have adaptive value, 
especially in hostile or changing environments [56]–[58]. In certain cases, the adaptive 
value of subpopulation formation is illustrated by experimental evidence [33], [59], 
[60]. 
In general, the evolutionary significance of the formation of bacterial subpopulations 
can be interpreted as the result of two different strategies: division of labor and bet-
hedging [53], [61], [62]. Division of labor, also known as cooperation, implies that there 
is an interaction between different phenotypes, and in a given environment both 
subpopulations together are fitter than any of them separately. In turn, bet-hedging 
occurs when each subpopulation is fitter than the other in a particular environment, so 
that the population as a whole is fitter in a variety of conditions and prepared to adapt to 
an environmental change.  
 
Formation of bacterial lineages is governed by diverse mechanisms, including 
programmed genetic rearrangement [63] and contraction or expansion of DNA repeats 
at genome regions known as contingency loci [64], [65]. In other cases, however, 
lineage formation is controlled by epigenetic mechanisms [54], [66]. Although the 
known examples of non-genetic heterogeneity show disparate levels of complexity, 
epigenetic formation of bacterial subpopulations typically fits in the following, 
simplified model: certain cell-to-cell differences can serve as physiological signals, and 
signal propagation by a feedback loop generates a heritable phenotype [54], [67]. Cell-
to-cell differences can be a consequence of environmental inputs or result from the 
noise intrinsical to many cellular processes [52], [54], [58]. An important factor that 
contributes to gene expression noise is the finite number effect: noise is more prevalent 
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if the number of molecules involved in a process is limited [68]–[70]. This is relevant in 
gene expression since transcription and translation events are relatively infrequent 
events, and also because transcription factors are often present in small numbers [71]. In 
turn, the feedback loops that propagate the initial state can be relatively simple (e. g., 
the perpetuation of autogenous control beyond cell division) or involve complex 
mechanisms like the formation of inheritable DNA adenine methylation patterns in the 
genome [54], [66], [72]. Some feedback loops are stable enough to cause bistability, the 
bifurcation of a bacterial population into two distinct phenotypic states [67]. If a 
feedback loop is metastable, reversion of the epigenetic state will occur after a certain 
number of cell divisions. Reversible bistability is usually known as phase variation, and 
typically involves reversible switching of gene expression from OFF to ON or from low 
to high expression [73]–[75]. Examples of phase variation have been described mostly 
in bacterial pathogens, and subpopulation formation is frequently viewed as a strategy 
that may facilitate evasion of the immune system during infection of animals [73]–[75]. 
This view is supported by the observation that phase-variable loci often encode 
envelope components or proteins involved in modification of the bacterial envelope 
[73], [75]. 
 
Dam methylation 
Base methylation is a DNA modification present in all kingdoms of life. C5-
methylcytosine and N6-methyl-adenine are found in bacterial, archaeal and eukaryotic 
genomes, whereas N4-methyl-cytosine is found only in bacteria [76], [77]. The methyl 
group of modified bases protrudes from the major groove of the double DNA helix, 
which is a typical place for recognition of DNA motifs by DNA-binding proteins [78]. 
Consequently, the methylation state of critical adenosine or cytosine moieties can 
regulate the interaction between DNA-binding proteins and their cognate DNA 
sequences [78], [79]. Formation of N6 -methyl-adenine (an probably of the other 
methylated bases) lowers the thermodynamic stability of DNA [80] and alters DNA 
curvature [81], which could further influence DNA-protein interactions.  
 
Base modification in bacterial genomes is performed by two kinds of DNA 
methyltransferases: (i) associated with restriction-modification systems that protect the 
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cell from foreign unmethylated DNA [82], [83]; (ii) solitary methyltransferases that do 
not have a restriction enzyme partner [79]. A paradigm of solitary methyltransferase is 
the Dam methylase of Gamma-proteobacteria. Dam is only found in a particular clade 
of bacteria consisting of the orders Enterobacteriales, Vibrionales, Aeromonadales, 
Pasteurellales, and Alteromonadales [84]. It is essential for viability in Vibrio cholerae 
and certain strains of Yersinia [85]. In Escherichia coli and Salmonella enterica, a dam 
mutation causes pleiotropic defects but is not lethal [86], [87]. Dam shares significant 
sequence identity with DNA methyltransferases such as MboI and DpnII, both of which 
have a restriction enzyme counterpart [84], [88]. This relatedness suggests that Dam has 
evolved from an ancestral restriction-modification system. A crucial difference, 
however, is that the Dam methylase is highly processive, able to perform multiple 
methylation reactions before dissociating from the DNA molecule, whereas restriction-
modification DNA methylases are distributive [89]. The Dam methylase transfers a 
methyl group from S-adenosyl-methionine to the N6 amino group of the adenosine 
moiety of 5’GATC3’ sites [86]. Methylation occurs shortly after DNA replication, 
which means that hemimethylated GATC sites are the natural substrate of the Dam 
methylase. However, Dam methylates hemimethylated and unmethylated GATC sites 
with similar efficiency [86]. DNA binding and/or methyl transfer efficiency are 
influenced by the flanking sequences of the GATC sites [90].  
 
N6 -methyl-adenine can be used as a signal for genome defense, DNA replication and 
repair, nucleoid segregation, regulation of gene expression, control of transposition, and 
host-pathogen interactions [84], [88], [91] [86] (Figure I3). Dam plays a crucial role in 
the correction of replication errors by providing a way to identify the template DNA 
strand [92]. The formation of a mismatched base pair results in recognition by the MutS 
protein and the recruitment and assembly of the MutHLS complex. Methyl-directed 
mismatch repair is initiated by MutH, which nicks the nonmethylated (newly replicated) 
DNA strand at the nearest hemimethylated GATC site, ensuring that the parental 
template strand is not altered [93]. Degradation and resynthesis of the mismatched 
daughter strand eventually result in correction of the mismatched sequence. 
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Figure I3. Examples of roles of N6-methyl-adenine in enteric bacteria. When known, the 
methylation-sensitive DNA-binding proteins involved in each process are indicated. Reproduced 
from [79]. 
 
Initiation of chromosome replication in E. coli requires binding of an ATP-bound form 
of the initiator protein DnaA to the replication origin (oriC), followed by separation of 
the two strands of the double helix and loading of DNA helicase. However, binding of 
DnaA at the oriC region is only possible if the GATCs located in the region are 
methylated; a hemimethylated origin is inactive [94]. Interestingly, the density of 
GATC sites in the oriC region is roughly tenfold higher than the average in the E. coli 
chromosome (11 GATC sites within 245 base pairs) [95]. Dam-dependent timing of 
DNA replication and nucleoid organization are controlled by a protein known as SeqA, 
which binds hemimethylated GATC sites in the oriC region, inhibiting further rounds of 
replication [96]. SeqA also binds to newly generated hemimethylated GATC sites along 
the chromosome, organizing the daughter chromosomes into nucleoid domains [97], 
[98]. 
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The involvement of Dam methylation in bacterial virulence was first described in 
Salmonella: the 50% lethal dose (LD50) of a dam mutant is 10,000 fold higher than that 
of the wild type upon oral inoculation [99], [100]. Pleiotropic effects caused by absence 
of Dam methylation might explain this extreme phenotype: dam mutants display lower 
invasion capacity, reduced motility, envelope instability, ectopic expression of fimbriae, 
sensitivity to bile salts, lower expression of virulence genes, and altered LPS O-antigen 
chain length [88], [101], [102]. 
 
Dam methylation-dependent transcriptional control of gene expression can be classified 
into two main types [103]:  
 
(I) Clock-like controls that use the methylation state of the DNA as a 
signal to couple gene expression to a particular stage of the cell cycle. Examples 
of transcriptional activation by GATC hemimethylation include the conjugal 
transfer gene traJ and the IS10 transposase gene [104], [105]. An example of 
repression by hemimethylation is provided by the gene dnaA, which encodes an 
initiator of chromosome replication [106].  
(II) Switch-like controls that turn on and off gene expression upon 
formation of differential methylation patterns at specific GATC sites. Such sites 
are typically found forming clusters at or near the promoters of phase variation 
loci [73]. 
 
Because active demethylation is not known to occur in bacteria, competition 
between DNA-binding proteins and Dam methylase is the only mechanism known 
to generate nonmethylation [66]. Successful exclusion of the Dam methylase from 
GATC sites requires a decrease in processivity, which occurs at GATC sites 
flanked by specific, AT-rich DNA sequences [90]. 
 
Phase variation systems regulated by Dam methylation 
We will briefly discuss three phase variation systems under Dam methylation control: 
pap and agn43 from Escherichia coli and opvAB from Salmonella enterica. 
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pap 
 
The pap operon encodes pyelonephritis-associated pili that mediate adhesion of 
uropathogenic E. coli to the urinary mucosa [107]. Synthesis of Pap pili is subjected to 
phase variation, and Dam methylation controls switching between ON and OFF states 
[72]. The regulatory region of the pap operon contains six binding sites for the leucine-
responsive regulatory protein, Lrp. Sites 5 and 2 contain GATC motifs known as 
GATCdist and GATCprox, respectively. In the OFF state, Lrp binds cooperatively and 
with high affinity to sites 1-3, and prevents RNA polymerase binding [66], [72], [107]. 
Lrp binding at sites 1-3 reduces the affinity of Lrp for sites 4-6, and preserves the 
nonmethylated state of GATCprox while GATCdist remains methylated. The high affinity 
of Lrp for nonmethylated GATCprox and its incapability to bind a methylated GATCdist 
generates a feedback loop that propagates the OFF state [72], [107]. Switching to the 
ON state needs translocation of Lrp to sites 4-6. Translocation involves the auxiliary 
protein PapI. The PapI/Lrp complex has higher affinity for GATC sites 4-6 than for 1-3 
GATCs [72]. Binding of Lrp to sites 4-6 hinders methylation of GATCdist and permits 
methylation of GATCprox, favoring the propagation of the ON state [107]. 
 
agn43  
 
The agn43 gene of E. coli encodes an autotransporter protein whose expression is 
subjected to phase variation under control of Dam methylation and the transcription 
factor OxyR [108]. Three GATC sites present within the binding site of OxyR at the 
agn43 regulatory region.  OxyR binding to nonmethylated agn43 GATCs represses 
transcription and prevents GATC methylation. In turn, methylation of GATC sites 
avoids OxyR binding [109]–[111]. agn43 expression thus depends on the competition 
between OxyR binding and Dam methylation, and switching may occur upon DNA 
replication [111], [112]. 
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Figure I4. Diagrams for Dam methylation-dependent regulation of pap, agn43 and opvAB 
phase variation. For simplicity, binding sites, Dam methylase and RNA polymerase are not 
represented. Adapted from  [113], [114]. 
 
opvAB 
 
The Salmonella enterica opvAB operon shows phase variation, which produces bacterial 
lineages with standard (OpvABOFF) and shorter (OpvABON) O-antigen chains in the 
lipopolysaccharide. Transcription of opvAB is controlled by the LysR-type factor OxyR 
and by Dam methylation. The opvAB regulatory region contains four sites for OxyR 
binding (OBSA-D), and four GATC motifs (GATC1-4) which are susceptible to be 
methylated by the Dam methylase. Regulation by OxyR is oxygen-independent [115]. 
OpvABOFF and OpvABON cell lineages present opposite DNA methylation patterns in 
the opvAB regulatory region: (i) in the OpvABOFF  state, GATC1 and GATC3 are non-
methylated, whereas GATC2 and GATC4 are methylated; (ii) in the OpvABON state, 
GATC2 and GATC4 are non-methylated, whereas GATC1 and GATC3 are methylated 
[114]. 
 
The OBSA and OBSC sites of opvAB are identical to the consensus sequence for OxyR 
binding while OBSB and OBSD are not. This difference may explain the higher stability 
of the OpvABOFF lineage, resulting in a ~600-fold difference between ON→OFF and 
OFF→ON transition rates. The predominant OFF state involves binding of OxyR to the 
OBSA and OBSC sites, which protects GATC1 and GATC3 from methylation. In this 
configuration, GATC2 and GATC4 are unprotected and therefore are methylated by 
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Dam. In the ON state, OxyR binds to the OBSB and OBSD sites. As a consequence, 
GATC2 and GATC4 are protected from methylation and remain non-methylated, while 
GATC1 and GATC3 are methylated. In this configuration, RNA polymerase is recruited 
to the opvAB promoter and transcription of opvAB takes place. Like other LysR-like 
transcription factors, OxyR may contact RNA polymerase within the DNA region 
occupied by the regulator [116]. Additional factors involved in the formation of OpvAB 
cell lineages are the GATC-binding protein SeqA which contributes to the stability of 
the OpvABOFF lineage, and the nucleoid protein HU which stabilizes the OpvABON 
lineage [114]. 
 
 
Figure I5. Model of opvAB phase variation. The diagram shows the Dam methylation states found 
in OpvABOFF and OpvABON cell lineages and the hypothetical patterns of OxyR binding to cognate 
sites. Black and white squares represent methylated and nonmethylated GATC sites, respectively. 
Adapted from [114]. 
 
The opvA and opvB genes encode inner membrane proteins that modulate the O-antigen 
chain length. The dramatic change in LPS structure caused by opvAB expression (see a 
diagram in Figure I6), renders S. enterica resistant to bacteriophages 9NA, Det7, and 
P22 due to the fact that the O-antigen is the bacterial surface receptor used by these 
bacteriophages [117], [118], [119, p. 22], [120] 
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Figure I6. Diagrams of lipopolysaccharide structure in the OpvAOFF and OpvABON 
subpopulations. Lipid A is represented in blue and core oligosaccharide in green. Every red circle 
represents five O-antigen repeat units. Modal lengths conferred by WzzST, WzzfepE and OpvAB 
are indicated. Adapted from [114]. 
Because opvAB phase variation is skewed towards the OFF state, S. enterica 
populations contain a major subpopulation of OpvABOFF (phage-sensitive) cells and a 
minor subpopulation of OpvABON (phage-resistant) cells. In the presence of a 
bacteriophage, the OpvABOFF subpopulation is killed and the OpvABON subpopulation 
is selected (Figure I7). Hence, the existence of a small subpopulation of phage-resistant 
cells preadapts S. enterica to survive phage challenge. In OpvAB– S. enterica, 
acquisition of phage resistance is mutational only, and a frequent mechanism is 
alteration of LPS structure. Because the LPS plays major roles in bacterial physiology 
including resistance to environmental injuries and host-pathogen interaction [121], 
opvAB phase variation may  have selective value by providing S. enterica with a non-
mutational, reversible mechanism of phage resistance. This mechanism offers the 
additional advantage of protecting Salmonella from multiple phages, perhaps from all 
phages that bind the O-antigen. 
Acquisition of phage resistance in OpvABON cells requires a payoff: reduced virulence 
in the mouse model. In a phage-free environment, this payoff may be irrelevant because 
the avirulent subpopulation is minor as a consequence of skewed switching of opvAB 
expression toward the OFF state: only 1/1,000 S. enterica cells can be expected to be 
avirulent in a phage-free environment. The virulence payoff is therefore enforced in the 
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presence of phage only, and its adaptive value may be obvious as it permits survival. On 
the other hand, the fitness cost of OpvAB-mediated phage resistance can be expected to 
be temporary only because phase variation permits resuscitation of the virulent 
OpvABOFF subpopulation as soon as phage challenge ceases. Resuscitation may actually 
be rapid as a consequence of skewed switching towards the OpvABOFF state.  
 
 
 
Figure I7. Phase variation of opvAB as a reversible bacteriophage resistance mechanism. 
Diagram for the selection of the OpvABON subpopulation in the presence of a bacteriophage that 
uses the O-antigen as receptor. OpvABOFF cells are represented in white, OpvABON
 
cells in blue. 
Adapted from [122] 
 
Lack of Dam methylation locks opvAB expression in the ON state [114]. Introduction of 
point mutations in the GATCs sites alters the regulation of the operon and produces 
different sizes of OFF and ON subpopulations [123]. 
Other phase-variable systems controlled by DNA adenine methylation play roles in 
bacteriophage resistance. In Haemophilus influenzae, DNA adenine methylation 
controls phase-variable resistance to bacteriophage HP1c1 but the underlying 
mechanism remains hypothetical [124]. Phase variation can also contribute to phage 
resistance without alteration of the bacterial surface. For instance, certain genes 
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encoding restriction-modification systems show phase variation [125], [126]. In other 
cases, Dam-dependent gene regulation controls the synthesis or modification of 
envelope structures such as fimbriae or the LPS O-antigen [127].  
 
Biosensors 
Biosensors are devices that combine biological materials and transducers for the 
detection of specific signals (e. g., chemical components, heavy metals, metabolites 
with economic interest, contaminants, microorganisms, control parameters, etc.). This 
occurs through the conversion of biochemical signals into quantifiable physicochemical 
signals that are proportional to the initial amount of sample. The first biosensor, 
developed in 1962, consisted of a biological device able to detect the presence of 
glucose [128]. Since then, biosensors of different types have been developed and 
marketed for various applications. Biosensors often provide a more specific, sensitive, 
rapid, real and reproducible results compared to chemical sensors. Indeed, conventional 
chromatographic methodologies such as gas chromatography (GC) or high-performance 
liquid chromatography (HPLC) are tedious and not portable while biosensors can offer 
rapid and on-site/point-of-care monitoring of even trace levels of targets [129]–[131]. 
Additional advantages are high specificity and tight interaction between biological 
molecules and target compounds. Several studies have focused on developing 
biosensors with high accuracy and sensitivity using enzymes or receptor proteins as the 
recognition elements, RNA, DNA, antibodies or whole cells [129], [132]–[134]. 
Although biosensors that use enzymes are widely used, the cost of production and 
purification is high, and cofactors are typically required to generate a measurable signal 
for certain targets [131]. 
The use of whole cells as sensing devices presents numerous advantages over enzymatic 
and protein systems due to the low cost and improved stability. Cofactors are present 
inside the cells, and production is reduced to one step, where the cell grows. Moreover 
microbes present high stability under harsh environments [131], [135]. Whole-cell 
biosensors usually measure changes in cellular metabolism such as pH or gene 
expression [136], [137]. 
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 Microorganisms have been used with a variety of sensing techniques including 
electrochemical and optical detection. The first monitors the electroactive species 
consumed or produced by these microorganisms by conductimetric, amperometric, 
impedimetric or potentiomentric methods. In contrast, optical techniques are based on 
the quantification of fluorescence, luminescence, color, etc. [131]. Microbial 
auxotrophy was used by Pfleger et al. in order to monitor growth-limiting small 
molecules such as mevalonate [136]. 
 
Reporter gene expression under the control of a specific regulatory network is another 
powerful readout with high sensitivity. Commonly used reporter genes are enzymes 
with activities detected through colorimetric, fluorescent, or luminescent readout 
methods [138]–[140]. A relatively large number of biosensors use either 𝛽-
galactosidase (𝛽-gal) or luciferase as reporter [138], [141]–[143].  
 
Fluorescent proteins are also widely utilized in microbial sensors because they do not 
need to be supplied with any substrate due to their autofluorescence. For example, the 
green fluorescent protein (GFP) has been widely used to measure gene expression and 
to study cell-trafficking mechanisms [144]. GFP has been used, for instance, in a 
number of whole-cell biosensors in order to detect environmental contaminants. 
However, a limitation is that the original GFP takes time to mature and is inactive under 
anaerobic conditions. Moreover, the goal of multiplexing different signal detection at 
the same time led to the engineering of fluorescent protein versions with different colors 
and enhanced stability and folding properties [145]. 
 
The design of sensors for the detection of pathogenic bacteria is a rapidly developing 
field, due to the importance of a specific and accurate diagnosis to prevent infectious 
diseases. Some biosensors are based on nucleic acids and have the advantage of being 
able to amplify the signal using PCR, which considerably increases their sensitivity. A 
limitation, however, is that PCR-based methods are not able to discriminate live and 
dead bacteria. Antibodies are also used in this kind of biosensors, and are useful to 
detect spores and toxins [146]. 
 
Development of biosensors to monitor bacterial levels in food products and water 
samples is a promising research topic. Phage-based biosensors have been successfully 
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used for detection of bacteria directly in fresh products such as milk [139], [140], broth 
[147], fresh tomato [148], and water [149]. 
 
Most phages recognize their host very specifically to the bacterial strain level, with 
exceptions like Listeria phage A511 that identifies, binds and kills within an entire 
genus [150]. The inherent ability of the phages to bind to their target pathogen has been 
exploited to design biosensor surfaces using physical and chemical functionalization 
[151].  
 
Due to the importance of detecting pathogenic strains in a more effective way, new 
biosensors are being developed that share many components with those developed years 
ago. Ansaldi et al., 2015, developed a bacteriophage-based biosensor that use a 
fluorescent reporter protein that will be synthesized, and thus detected, only once the 
specific recognition step between a genetically modified temperate bacteriophage and 
its bacterial host has occurred [152]. 
 
 Bacteriophages 
Bacteriophages are classified into eight different major phyla, with different molecular 
lifestyles and distant relatedness, if any [153]. Tailed bacteriophages include 95% of all 
the phages reported so far in the scientific literature, and probably make up the majority 
of phages in nature [154]. It is estimated that there are at least 1031 tailed virions in the 
biosphere, and that phages are 10 to 25-fold more abundant than their bacterial hosts 
[155]–[157], which makes phage the predominant biological entity on our planet [155], 
[158]. Their abundance and ability to kill their bacterial hosts means that they play a 
critical role in virtually all natural processes. Phages are known to alter competition 
between bacterial strains and species [159], [160], to maintain bacterial diversity [161], 
[162], and to mediate horizontal gene transfer between bacteria [163], [164]. Phages and 
bacteria are in a constant arms race that results in continuous cycles of mutually 
influenced co-evolution [165], [166]. As an example, the adsorption machinery is the 
most rapidly evolving part of the tailed phage genome [167]. In turn, bacterial defense 
systems also show high variability (including phase variation) [127], rapid evolution, 
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and frequent horizontal gene transfer [168]. The specificity in the interaction between a 
bacteriophage and a bacterial cell is mostly determined by the specificity of adsorption, 
which is in turn dependent on the nature and structural peculiarities of the receptors that 
are recognized on the surface of the bacterial envelope  [169]. Known receptors of 
Salmonella phages are the LPS O-antigen [170], [171, p. 7], [172], [173], flagellar 
proteins [174], [175], [176, p. 5], the outer membrane protein for vitamin B12 uptake 
BtuB [175], [177], the outer membrane protein OmpC [178], [179], the outer membrane 
protein for drug efflux pump TolC [180], the outer membrane transport protein FhuA 
[181], and the Vi capsular antigen [182]. 
A common feature of bacteriophages using the O-antigen as receptor is that their tail 
spike proteins not only recognize but also hydrolyze the O-antigen, allowing the phage 
to penetrate through the O-antigen layer during infection [183]. Tailed phages have 
been traditionally assigned to the order Caudovirales and share a common structure 
consisting of a polyhedral, often icosahedral, head that contains a double-stranded DNA 
genome and is attached to a flexible tail. They also share a similar DNA packaging 
system relying on an ATP cleavage-powered DNA translocase [184]. Tailed phages can 
undergo a lytic or lysogenic life cycle. Lytic infection results in production of phage 
progeny and destruction of the host. During lysogenic infection, formation of a 
prophage may involve integration of the phage genome into the host chromosome or 
persistence as an extrachromosomal element. Genes that are expressed from the 
prophage can alter certain traits of the bacterial host. Under stressful conditions (e. g., 
DNA damage), prophages can be induced and resume a lytic cycle [185]. The 
bacteriophages used in this work belong the traditional three families in the order 
Caudovirales: P22 is a Podoviridae (which includes 14% of tailed phages), 9NA, a 
Siphoviridae (62%), and Det7, a Myoviridae (24%) [153]. These families are defined by 
their morphology: the Podoviridae have short non-contractile tails, the Siphoviridae 
have long non-contractile tails, and the Myoviridae have long contractile tails (Figure 
I8). 
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Figure I8. Idealized structures of bacteriophages belonging to the three families in the order 
Caudovirales. Podoviridae have short non contractile tails. Siphoviridae have long non-contractile 
tails. Myoviridae have long contractile tails. Modified from [WIKIPEDIA]. 
 
A recent classification based on sequence similarity of 337 fully sequenced tailed 
phages infecting 18 bacterial genera belonging to the Enterobacteriaceae family [186] 
identified 56 different clusters and confirmed that, although tail morphology has been 
shown not to be the best indicator of relatedness [187], [188], P22, 9NA and Det7 
belong to different groups indeed. P22 belongs to the lambda supercluster of temperate 
phages. P22_H5 is a virulent version of P22 called carrying a mutation in the c2 gene 
that prevents lysogeny [189]. 9NA constitutes the prototype phage of an isolated cluster 
which no close relatives. It forms clear plaques with no indication of a lysogenic 
lifestyle [118]. Det7 is also lytic [190, p. 7] and belongs to the Vi01-like cluster, which 
is distantly related to T4 [186], [191]. Clustering of the bacteriophages also showed a 
correlation with genome size and lifestyle. Again, the three phages were placed in three 
different groups: small temperate phages (P22, 44 Kb genome), small lytic phages 
(9NA, 53 Kb) and large phages (Det7, 158 Kb). Resistance to bacteriophages can be 
attained by a variety of mechanisms [192], including inhibition of DNA penetration, 
production of restriction endonucleases and blockage of the receptor by increased 
production of the extracellular matrix. However, the most frequent cause of phage 
resistance is a mutation that affects phage receptors [120], [192], [193]. Resistance to 
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phages comes at a fitness cost due to deleterious effects of resistance mutations [194], 
decreased ability to metabolize carbon [195], reduced competitive ability [196], 
increased susceptibility to other phages [197] and reduction in virulence [198], [199]. 
This may explain the adaptive value of phase variation in bacterial defense mechanisms 
[114], [124], [200]. 
 
Bacteriophage T5 
Bacteriophage T5 is a caudal virus belonging to the Siphoviridae family. This 
bacteriophage specifically infects E. coli bacterial cells and follows a lytic life cycle. 
The T5 structure includes a 90 nanometers icosahedral capsid and a 250 nanometer-long 
flexible, non-contractile tail. The capsid contains the phage's 121,750 base pair double-
stranded DNA genome [201]. T5 infects E. coli upon binding of its receptor-binding 
protein, Pb5, to the outer membrane ferrichrome transporter, FhuA [202]. This leads to 
a rearrangement of the tail that trigers DNA injection [203]. T5 has a peculiar way of 
infection in two steps. During the first step, only 8% of the genome is injected, leading 
to take-over of the host. During the second step, T5 DNA injection resumes and the 
lytic particles are formed [204].  
 
FhuA: Ferrichrome outer membrane transporter/phage receptor 
 
FhuA is an E. coli outer membrane protein which transports the ferric siderophore 
ferrichrome and is the receptor for phage T5, φ80 and T1 and for colicin M [205]. 
Cristal structures of FhuA are similar to other porin proteins, FhuA consists of a β-
barrel (composed 22 instead of 16 antiparallel β strands for porins), but unlike the porin 
proteins, it contains a plug (or cork or hatch) which fills the lumen of the barrel. The 
plug is a globular N-terminal domain that enters the β-barrel from the periplasmic side 
and tightly closes the pore in the β-barrel. The β-barrel extends well above the lipid 
bilayer. The β-strands are connected by short periplasmic turns and extracellular loops 
of up to 31 residues [206], [207]. 
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Bacteriophage T5-encoded lipoprotein 
Bacteriophage T5-encoded lipoprotein (llp gene) is synthesized upon E. coli infection, 
and prevents superinfection of the host cell by the same virus. The molecular basis of its 
ability to inactivate the receptor of phage T5, the FhuA protein, has been investigated in 
vitro [208]. In the early stage of infection of E. coli by bacteriophage T5, the phage-
encoded llp gene is expressed. Synthesis of Llp not only prevents superinfection but 
also protects progeny phages from being inactivated by the receptor molecules present 
in envelope fragments of lysed host cells [209].
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Phage therapy 
The first attempts to eradicate infections with phage therapy involved treatment of 
dysenteric humans [210]. The use of the bacteriophage to treat bacterial infection 
initially yielded impressive results. However, many problems soon appeared, such as 
the lack of reproducibility and the impossibility of achieving quality controls [211]. In 
addition, the discovery of antibiotics further decreased interest in phage therapy 
research in Western countries. In contrast, phage therapy continued in the Soviet Union 
and Eastern Europe. In the 80s, due to the emergence of resistance to antibiotics, some 
research groups focused on phage therapy as an alternative to the use of these 
antibiotics. [212].  
Advantages of phage therapy over use of antibiotics include that method phages 
isolation is fast, simple and inexpensive, and that resistance to phage develops about ten 
times more slowly than antibiotic resistance [213]. Furthermore, the fact that phages 
continue replicating as long as host bacteria are present [214] means that a small 
amount of phages could be used to carry out a treatment. Moreover, most phages have 
high host specificity, which may constitute an advantage in the treatment of chronic 
diseases where the microbiota is affected by the use of broad-spectrum antibiotics. On 
the other hand, phage therapy is harmless for humans since phage do not infect 
eukaryotic cells [213], However, more studies are needed to understand interactions 
between phage and the human immune system [215]. 
 
Recent investigations using animal models have explored phage treatment against a 
range of clinically significant pathogens. When challenged with gut-derived sepsis due 
to Pseudomona aeruginosa, oral administration of phage saved 66.7% of mice from 
mortality compared to 0% in the control group [216]. A single dose of phages used as 
prophylaxis in a Hamster model of Clostridium difficile-induced ileocecitis was 
sufficient prophylaxis against infection, saving 11 of 12 mice whereas control animals 
receiving C. difficile and clindamycin died within 96 h [217]. 
 
The Eliava Institute of Bacteriophage, Tbilisi, Georgia, and the Institute of Immunology 
and Experimental therapy in Wroclaw, Poland, have extensively used phage in 
preclinical and clinical treatment of common bacterial pathogens such as 
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Staphylococcus aureus, Escherichia coli, Streptococcus spp., P. aeruginosa, Proteus 
spp., Shigella dysenteriae, Salmonella spp., and Enterococcus spp. [218]. In a 1938 
clinical trial, 219 patients with bacterial dysentery were treated solely with a phage 
cocktail consisting of a variety of phages targeting Shigella spp., E. coli, Proteus spp., 
P. aeruginosa, Salmonella typhi, Salmonella paratyphi A and B, Staphylococcus spp., 
Streptococcus spp. and Enterococcus spp.; cocktails were administered both orally and 
rectally. Overall 74% of the 219 patients showed improvement or were completely 
relieved of symptoms [219], [220]. More recently, six patients with antibiotic 
unresponsive diabetic foot ulcers were treated in the USA by topical administration with 
S. aureus-specific phage. One application of this phage was enough for recovery in all 
individuals [221]. 
 
Currently, in Europe some phage preparations have approved by local authorities from 
Belgium, Poland and France for compassionate usage. In the U. S. A., several 
commercial phage preparations used for biocontrol of bacterial pathogens in the food 
industry have been approved by the FDA under the classification of “generally 
considered as safe”. Evidence suggests that phage biocontrol can be an effective method 
for improving food safety at numerous stages in meat production and processing. For 
example, Atterbury and colleagues [222] used phages to control C. jejuni contamination 
on the surface of chicken skin. After 24 hours post-administration, the treatment with 
phages resulted in a 1-1.3 log reduction in C. jejuni. In another trial, Hungaro et al. 
[223] used a mixture composed of a phage in combination with chemical agents 
(dichloroisocyanurate, peroxyacetic acid and lactic acid) to treat S. enteritidis on 
chicken skin. A reduction of 1-log CFU / cm2 was shown. Phages have been also used 
to reduce bacterial contamination in fruits, vegetables, and dairy products. For example, 
Levenrentz et al.  [224] attempted phage therapy against Salmonella on fresh fruit. The 
literature on phage therapy has also reported applications in sheep [225], cattle  [226], 
swine [227] and poultry [228]–[230]. 
 
DNA methylation, a potential target for novel antibiotics 
The involvement of Dam methylation in bacterial virulence was initially shown in the 
mouse model of typhoid: the "lethal dose 50" (LD50) of a dam mutant of Salmonella 
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enterica serovar Typhimurium is 10,000-fold higher than that of the wild type upon oral 
ingestion [100]. This extreme attenuation reflects the pleiotropic defects in dam 
mutants: (i) reduced colonization capacity due to inefficient activation of genes in 
pathogenicity islands 1 (SPI-1) and SPI-5 [100], [231], [232]; (ii) envelope instability, 
with release of outer membrane vesicles and leakage of proteins [233]; (iv) ectopic 
expression of fimbriae [231]; and (v) sensitivity to bile salts [233]. In the related serovar 
Enteritidis, altered O-antigen chain length in the lipopolysaccharide may contribute to 
attenuation [101]. 
An intriguing connection between DNA adenine methylation and virulence is found in 
the grampositive pathogen Mycobacterium tuberculosis. Strains of the Euro-American 
lineage of M. tuberculosis harbor a DNA adenine methyltransferase called MamA, 
which is absent from strains of the Beijing lineage [234]. MamA methylation appears to 
control survival in hypoxia, a stress condition typical of human infections, and may 
affect expression of a number of M. tuberculosis genes. A different DNA adenine 
methyltransferase is found in the Beijing lineage, suggesting that strain-specific 
differences in DNA methylation may control certain lineage-specific features [234]. 
Virulence-related defects associated with loss of DNA methylation have been reported 
in other pathogens. Certain strains of Haemophilus influenzae require Dam methylation 
for efficient invasion of both endothelial and epithelial cell lines [235]. Reduced 
invasion of epithelial cells by dam mutants is likewise observed in the periodontal 
disease agent Aggregatibacter actinomycetemcomitans [236] and perhaps in the 
intestinal pathogen Campylobacter [237]. A potential role of Dam methylation in 
virulence has been also described in the oral pathogen Streptococcus mutans [238]. 
Other virulence-related phenotypes of dam mutants are more difficult to interpret, and 
relevant examples are increased pedestal formation [239] and control of Shiga toxin 2 
production in dam mutants of enterohemorrhagic Escherichia coli OH157:O7 [240]. 
In bacterial pathogens where DNA adenine methylation is essential, the involvement of 
Dam methylation in pathogenesis has been tested by Dam methylase overproduction. 
Among Gamma-proteobacteria, overproducers of Dam methylase are attenuated in 
Vibrio cholerae, Aeromonas hydrophyla, Yersinia spp., and Pasteurella multocida 
[241]. Dam overproducers of Yersinia enterocolitica show enhanced invasion capacity, 
probably associated to transcriptional alterations in invasion genes and to changes in the 
composition of lipopolysaccharide (LPS) O-antigen. Furthermore, Y. enterocolitica 
Dam overproducing-strains show enhanced motility and impaired secretion of the 
Introduction 
 42 
pathogenicity factors called "Yersinia outer proteins" [85], [242]. Among Alpha-
proteobacteria, overproduction of CcrM methylase decreases proliferation of Brucella 
abortus inside murine macrophages, suggesting that CcrM methylation may control 
intracellular replication, which is a hallmark of Brucella infections [243]. 
The involvement of Dam methylation in the virulence of Salmonella and other Gamma-
proteobacterial pathogens has raised the possibility of using strains lacking DNA 
adenine methylation as live vaccines. Such vaccines have been assayed indeed against 
S. enterica, Haemophilus influenzae, and Yersinia pseudotuberculosis [244]. 
Hypermutation, however, is a negative trait that may hamper the use of dam mutants as 
live vaccines, especially in humans. 
Another potential application of DNA methylation research is the use of DNA 
methylase inhibitors as antibacterial drugs [245], [246]. Because adenine methylation is 
rare or absent in mammalian cells, DNA adenine methylase inhibitors should be 
harmless for the host. In pathogens in which DNA methylation is not essential, DNA 
adenine methylase inhibitors would attenuate virulence by transforming wild-type 
bacteria into phenocopies of dam mutants. Such drugs might have broad spectrum as 
DNA methylation is essential for virulence in many bacterial pathogens. Because DNA 
methylation is dispensable in many bacterial taxa and absent in others, inhibitors of 
DNA adenine methylases should be harmless for the normal microbiota. Hence, DNA 
adenine methylation inhibitors might approach the holy grial of antibacterial therapy: 
they would be harmless for the host and efficient against the pathogen without 
impairment of the pathogen’s fitness.  
A well known inhibitor of DNA methylation is sinefungin, a naturally occurring 
nucleoside isolated from cultures of Streptomyces griseolus and S. incarnatus. 
Sinefungin is structurally related to S-adenosyl-methionine (SAM) and S-adenosyl-L-
homocysteine (SAH) [247], and exerts a potent, competitive inhibition of eukaryotic 
DNA methyltransferases [248].  
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Appendix 1 
Lipopolysaccharide (LPS) 
 
The cell envelope of Gram-negative bacteria consists of three layers: the cytoplasmic or 
inner membrane, the peptidoglycan cell wall, and the outer membrane. The outer 
membrane is highly asymmetrical: its inner leaflet consists mainly of phospholipids, 
while the outer leaflet is almost entirely composed of a particular kind of glycolipid 
known as lipopolysaccharide (LPS) [249]. 
 
 The LPS is essential for many aspects of the lifestyle of Salmonella, including 
swarming motility [250]; intestinal colonization [251]; invasion and intracellular 
replication [252]–[254]; and resistance to serum [255], [256], bile [257], and cationic 
peptides [254]. LPS is also a common receptor for bacteriophages [120]. The LPS can 
be divided in three structural regions: lipid A (endotoxin), a highly conserved 
hydrophobic molecule which serves as an anchor to the membrane; the core saccharide, 
a genus-conserved short oligosaccharide; and the O-antigen, an immunogenic molecule 
made up by a number of repeats of the same saccharide unit composed of three to five 
sugars [258], [259] (Figure I9). Most of the structural diversity of LPS is found in the 
O-antigen. Altered sugar composition, linkage, and number of O-antigen repeats lead to 
the production of many different kinds of O-antigen molecules both between and within 
bacterial strains.  
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Figure I9. A. Idealized structure of an LPS molecule. For simplicity, only four O-antigen repeat 
units are represented, but individual LPS molecules can have more than 100 O-antigen repeat units. 
B. Visualization in SDS-PAGE gel of a typical LPS structure from Salmonella enterica. The O-
antigen chain modal lengths imposed by the regulators WzzST and WzzfepE are indicated. Adapted 
from [122]. 
 
Synthesis of the O-antigen is complex and involves a large number of inner membrane 
proteins [260]. First, synthesis of a single O-antigen repeat unit linked to the lipid 
carrier undecaprenyl pyrophosphate takes place in the cytoplasmic leaflet of the inner 
membrane. The lipid-linked O-antigen unit is then flipped to the periplasmic leaflet of 
the inner membrane by the O-antigen flippase Wzx. In the periplasm, the O-antigen 
polymerase Wzy (also called Rfc in Salmonella) combines O-antigen repeat units in a 
growing O-antigen chain until preferred modal lengths conferred by O-antigen chain 
length regulators (also known as polysaccharide copolymerases or PCPs and commonly 
designated Wzz) are produced. Once the O-antigen chain is complete, it is ligated to the 
lipid A-core by the O-antigen ligase WaaL and tranported to the outer membrane 
(Figure I10) 
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Figure I10. Diagram of the synthesis of O-antigen. 1. O-antigen repeat unit synthesis on the 
undecaprenyl pyrophosphate-lipid carrier in the cytoplasmic leaflet of the inner membrane. 2. 
Flipping of the lipid-linked O-antigen subunit to the perisplasmic leaflet by the O-antigen 
flippase Wzx. 3. Transfer to the O-antigen polymerase Wzy. 4. Addition of single lipid-linked 
O-antigen subunits to the growing O-antigen chain. 5. Length regulation of the O-antigen chain 
by O-antigen chain regulators Wzz. 6. Ligation of the polymerized O-antigen chain to a lipid A-
core molecule by the O-antigen ligase WaaL. Reproduced from [261]. 
 
Visualization of LPS in SDS-PAGE gels results in a typical “ladder” structure in which 
every step reflects the addition of a single O-antigen repeat unit (Figure I9B). Different 
O-antigen chain modal lengths are easily identified within the same bacterial strain by 
increased intensity of bands of a particular size range. As already stated, O-antigen 
chain modal lengths depend on O-antigen chain length regulators. As many other 
species in the Enterobacteriaceae family [262], Salmonella enterica displays two modal 
lengths (Figure I9B): long O-antigen (16-35 repeat units) is conferred by WzzST (also 
known as Rol, Cld or WzzB) [263], and very long O-antigen (>100 repeat units) by 
WzzfepE (FepE) [262]. In the absence of both Wzz regulators, Salmonella LPS displays a 
stochastic distribution, with bands decreasing in intensity as the O-antigen chain grows 
longer. Albeit with remarkable variations in amino acid sequence, Wzz regulators share 
several structural properties: nearly all harbor transmembrane segments near the N and 
C termini and a hydrophilic α-helical periplasmic domain containing a coiled-coil 
region [264, p. 2] and display a particular set of conserved amino acid residues near the 
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N terminus [265]. Wzz regulators are known to form oligomers in a characteristic bell 
shape [266]. The mechanism for regulation of O-antigen chain length by Wzz regulators 
is not established and has been the subject to considerable debate. Depending on the 
model, Wzz regulators have been proposed to act as molecular timers that modulate the 
ability of Wzy to elongate the O-antigen chain [267], as chaperones that assemble O-
antigen synthesis machinery proteins in particular ratios [268], as scaffolds in which O-
antigen chain lengths are conferred by the number of Wzz subunits in a given oligomer 
[265] or as rulers that set O-antigen chain length by direct interaction to the O-antigen 
chain [269]. Later on, the role of changes in the structure of the growing O-antigen in 
the interaction with the Wzz regulators has been incorporated into a chain-feedback 
model [270]. A hybrid model combining ruler and chain-feedback elements has been 
recently proposed, and is supported by a large body of evidence [260]. According to this 
model, the interaction between Wzy and Wzz favors the formation of a longer O-
antigen chain by direct binding of the growing O-antigen chain to the Wzz protein. 
However, when the O-antigen chain attains a particular length, higher-order structures 
begin to destabilize the interaction with Wzz. When the O-antigen chain reaches the tip 
of the bell-shaped Wzz oligomer, the lipid-linked O-antigen is freed from the O-antigen 
synthesis complex rendering it susceptible to ligation by WaaL to form a mature LPS 
molecule. The LPS molecule is subsequently exported to the outer membrane at a 
limited number of sites, in a ribbon-like shape that is largely immobile [271]–[273], 
probably due to strong lateral interactions between LPS molecules [274], [275]. These 
interactions induce the assembly of a mechanically stable network in which the 
structure of the lipid A-core is rigid and well-defined [276] but the O-antigen is flexible 
and can adopt many conformations [277]. Ribbon-like dispositions have also been 
described for many inner and outer membrane proteins, suggesting that the whole cell 
envelope might be organized in a helical fashion [273], [278].  
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Appendix 2 
Antibiotic heteroresistance  
 
Heteroresistance is a phenomenon where subpopulations of a bacterial isolate exhibit a 
range of susceptibilities to a particular antibiotic. The first report that described 
heteroresistance was published in 1947, and described the phenomenon in Haemophilus 
influenza [279]. The term 'heteroresistance' was not used until 1970 [280]. 
Heteroresistance complicates the global crisis of resistance to antibiotics. Frequently, 
the clinical diagnostic tests are not effective in detecting a heteroresistant 
subpopulation, which goes unnoticed and conbtributing to treatment failure [281]. 
Heteroresistance in many ha been detected in both Gram-negative and Gram-positive 
bacteria [282], [283]. 
 
A relevant example is colistin heteroresistance. Polymyxin E, usually known as colistin, 
is a polycationic antibiotic that acts by replacing Ca2+ and Mg2+ in the LPS, causing loss 
of membrane integrity and cell death [284]. Colistin heteroresistance was first detected 
in 2006 in clinical isolates of Acinetobacter baumanii. Since then the number of 
publications which are reporter colistin heteroresistence in clinical isolates of different 
Gran-negatives is increasing [285]–[288]. Resistance towards polymyxins in gran 
negative bacteria can be caused by: (i) alterations in the LPS that decrease its net 
negative charge [284], [289], [290]; (ii) loss or modification of lipid A [291]; (iii) 
activation of efflux pumps [292]; and (iv) capsule shedding [293]. Heteroresistance can 
be caused by mutation [294], [295] or by gene amplification [296]. For instance, 
variations in the copy number of the pmrD gene cause colistin resistance in Salmonella 
enterica [282]. 
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The overall objective of this Thesis is the exploitation of the opvAB phase variation 
system of Salmonella enterica for the design of biological sensors. The background 
information necessary to address this goal has been provided by previous studies of our 
laboratory. The specific objectives addressed in the Thesis are as follows: 
 
1. Engineering of genetic constructs for bistable expression of heterologous genes under 
opvAB control. 
 
2. Tests of bistable expression under opvAB control in a heterologous host, Escherichia 
coli. 
 
3. Design and experimental testing of a sensor of inhibition of DNA methylation. 
 
4. Design and optimisation of opvAB-based biosensors capable of bacteriophage 
detection. 
 
5. Design of biosensors for bacteriophage receptor discrimination. 
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Bacterial strains 
Strains of Salmonella enterica and Escherichia coli used in this study are listed in Table 
1. S. enterica strains belong to serovar Typhimurium, and derive from the mouse-
virulent strain ATCC 14028. For simplicity, S. enterica serovar Typhimurium is 
routinely abbreviated as S. enterica. Unless indicated otherwise, E. coli strains derive 
from K12 MG1655 (E. coli Genetic Stock Center). 
Strain construction by targeted gene disruption was achieved using plasmids pKD3, 
pKD4 or pKD13 as templates to generate PCR products for homologous recombination 
[297]. Antibiotic resistance cassettes introduced during strain construction were excised 
by recombination with plasmid pCP20 [297]. Primers used in strain construction are 
shown in Table 2. For the construction of translational lac fusions on the S. enterica 
chromosome, FRT sites generated by excision of KmR cassettes were used to integrate 
plasmid pCE40 [298]. Transductional crosses using phage P22 HT 105/1 int201 were 
used for transfer of chromosomal markers between S. enterica strains [152]. To obtain 
phage-free isolates, transductants were purified by streaking on green plates [299]. 
Phage sensitivity was tested by cross-streaking with the clear-plaque mutant P22 H5. 
Bacteriophage P22 H5 is a virulent derivative of bacteriophage P22 that carries a 
mutation in the c2 gene [189], and was kindly provided by John R. Roth, University of 
California, Davis. Directed construction of point mutations was achieved using the 
QuikChange® Site-Directed Mutagenesis Kit (Stratagene) using the suicide plasmid 
pDMS197 [247] and propagated in E. coli CC118 λ pir. Plasmids derived from 
pMDS197 were transformed into E. coli S17-1 λ pir. The resulting strains were used as 
donors in matings with S. enterica. 
 
Restoration of O-antigen 
E.coli K12 MG1655 is unable to synthesize O-antigen due to a disruption of the wbbL 
gene, which encodes rhamnose transferase. The activity of this enzyme is necessary for 
the correct composition of the O-antigen [300], [301]. For restoration of the O-antigen, 
a DNA fragment was amplified using oligos SacI-wbbl1 and XbaI-wbbl2. The resulting 
PCR fragment was cloned onto plasmid pDMS197 [302] to obtain plasmid 
pDMS::wbbL. This plasmid was propagated in E.coli CC118 λ pir. Plasmids derived 
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from pDMS197 were transformed into E.coli S17 λ pir. The resulting strain was used as 
donor in matings with DR40 harboring a KmR cassette from pKD4. TcR transconjugants 
were selected on E plates supplemented with tetracycline. Several TcR transconjugants 
were grown in nutrient broth (beef extract, 5 g/l; peptone, 5 g/l) and plated on nutrient 
broth supplemented with 5% sucrose. Individual tetracycline-sensitive segregants were 
then screened for kanamycin sensitivity and characterized by DNA sequencing using 
external oligonucleotides of the fragment. The resulting strain, DR28, is a derivative of 
DR3. 
 
Table M1. List of strains of S. enterica and E.coli constructed  in this study. 
Strain Genotype 
S. enterica serovar Typhimurium 
ATCC 14028 Wild type 
SV6727 opvAB:gfp 
SV6729 opvAB:gfp GATC-less 
SV8499 PopvAB::lacZY 
SV8578 opvAB::gfp GATC1,2 
SV9700 PopvAB::lacZY::gfp 
SV9701 PopvAB GATC1,2::lacZY::gfp 
SV9702 PopvAB GATC-less ::lacZY::gfp 
SV9703 PopvAB::BI-aac6::gfp 
SV9704 PopvAB::D25-aac6::gfp 
SV9705 PopvAB GATC-less::BI-aac6::gfp 
SV9706 PopvAB::BI-ctxm::gfp 
SV9707 PopvAB GATC-less::BI-ctxm::gfp 
SV9716 PopvAB::lacZY 
SV9776  PopvAB::BI-aac3::gfp 
SV9777  PopvAB::gfp 
SV9792 PopvAB::D25-aac3::gfp 
SV10048 PopvAB GATC1,3::BI-aac6::gfp 
SV10049 PopvAB GATC4::BI-aac6::gfp 
E. coli 
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MG1655 Wild type 
CC118 λ pir phoA20 thi-1 rspE rpoB argE(Am) recA1 (lambda pir) 
S17 λ pir  recA pro hsdR RP4-2-Tc::Mu-Km::Tn7 (lambda pir) 
DR3 ∆lacZY 
DR22 ∆lacZY PopvAB::lacZY::gfp 
DR23 ∆lacZY PopvAB GATC1,2::lacZY::gfp 
DR24 ∆lacZY PopvAB GATC-less::lacZY::gfp 
DR28 ∆lacZY LPS+ 
DR29 ∆lacZY opvAB::gfp LPS+ 
DR30 ∆lacZY GATC-less opvAB::gfp LPS+ 
DR40  ∆IS5::km 
DR41 E. coli MG1655 PopvAB::llp::gfp 
DR42 E. coli MG1655 ∆fhuA 
 
Bacteriophages 
Bacteriophages 9NA [303], [118], Det7 [38] and HK620 [304] were kindly provided by 
Sherwood Casjens, University of Utah, Salt Lake City. Bacteriophage P22_H5 is a 
virulent derivative of bacteriophage P22 that carries a mutation in the c2 gene [189], 
and was kindly provided by John R. Roth, University of California, Davis. 
Bacteriophages Se_F1, Se_F2, Se_F3 and Se_F6 infecting S. enterica were isolated and 
purified from waste water obtained at various locations around Seville. Se_AO1 was 
isolated from a sheep farm. Se_ML1 bacteriophage was isolated and purified from 
samples taken at ponds of Maria Luisa Park in Seville (37°22'28.0"N 5°59'19.1"W). 
Additional bacteriophages were isolated using strain DR28 as host (E.coli MG1655 ∆𝑙𝑎𝑐𝑍𝑌 LPS+). Ec_Unk_EM1, Ec_Unk_EM1.1, Ec_Unk_EM2 were isolated from 
waste water from Seville, Ec_Unk_AO1 was isolated in a water sample from a sheep 
farm, and Ec_Unk_ML, Ec_Unk_ML1 and Ec_Unk_MLB were isolated from water 
samples from Maria Luisa Park, Seville. Ec_Unk_PO1, Ec_Unk_PO2 and 
Ec_Unk_PO3 were isolated from a chicken farm. A full list of phages is presented in 
table M2. 
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Table M2. List of bacteriophages used in this work. 
Bacteriophage Host Origin 
P22 S. enterica Sherwood Casjens lab 
Det7 S. enterica Sherwood Casjens lab 
9NA S. enterica Sherwood Casjens lab 
T5 E.coli MG1655 Pascale Boulanger 
Se_F1 S. enterica Seville, Spain (waste water) 
Se_F2 S. enterica Seville, Spain (waste water) 
Se_F3 S. enterica Seville, Spain (waste water) 
Se_F6 S. enterica Seville, Spain (waste water) 
Se_ML1 S. enterica Seville, Spain (Maria Luisa Park) 
Se_AO1 S. enterica Seville, Spain (Sheep farm) 
Ec_Unk_EM DR28 Seville, Spain (waste water) 
Ec_Unk_EM1 DR28 Seville, Spain (waste water) 
Ec_Unk_EM2 DR28 Seville, Spain (waste water) 
Ec_Unk_AO1 DR28 Seville, Spain (sheep farm) 
Ec_Unk_ML DR28 Seville, Spain (Maria Luisa Park) 
Ec_Unk_ML1 DR28 Seville, Spain (Maria Luisa Park) 
Ec_Unk_MLB DR28 Seville, Spain (Maria Luisa Park) 
Ec_Unk_PO1 MG1655 Cáceres, Spain (chicken farm) 
Ec_Unk_PO2 MG1655 Cáceres, Spain (chicken farm) 
Ec_Unk_PO3 MG1655 Cáceres, Spain (chicken farm) 
 
Culture media 
Bertani's lysogeny broth (LB) was used as standard liquid medium for S. enterica and E. 
coli. Solid LB contained agar at 1.5% final concentration.  
 g/l 
Tryptone 10 
Yeast extract 5 
NaCl 10 
  
EBU: rich medium used to discard the presence of lysogenic isolates after transduction. 
EBU is LB medium supplemented with the following components: 
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 ml/l 
K2HPO4 25% 10 
Glucose 50% 5 
Fluorescein 1% 2.5 
Evans Blue 1% 1.25 
 
SOB: rich medium used to grow competent cells during recovery: 
 
 g/l 
Tryptone 20 
Yeast extract 5 
NaCl 0.5 
KCl 0.19 
pH 7 Adjusted with NaOH 
After autoclaving, 5 ml of MgCl2 2M is added 
 
NCE: No-carbon essential (NCE) medium was supplemented with glucose (0.2%) or 
lactose (0.2%) after autoclaving. 
 
 ml/l 
50× NCE salts 20 
MgSO4 1M 1 
 
Antibiotics 
Antibiotic Stock concentration (mg/ml) Final concentration (µg/ml) 
Ampicillin  100 100 
Chloramphenicol  20 20 
Kanamycin  50 50 
Tetracycline 12 12 
Cefotaxime 40 40 
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Growth conditions 
S. enterica cultures were routinely grown at 37oC, and exceptionally at 30oC due to 
plasmid thermosensitivity. For microaerophilic conditions, 5 ml of bacteria were 
incubated at 37 oC without shaking in 10 ml plastic tubes.  
 
Solutions 
 
PBS 
 mM 
NaCl 1,370 
KCl 27 
Na2HPO4 · 7H2O 43 
KH2PO4 14 
pH 7.3 
 
 
NCE salts 50× 
  g 
KH2PO4 197 
K2HPO4 ·3H2O 323 
NaNH4HPO4·4H2O 175 
 
Bacterial transduction 
Lysates 
 
To prepare a bacteriophage lysate, 4 ml of bacteriophage broth was mixed with 1 ml of 
an overnight culture of the host strain. The mixture was incubated  at 37 oC with shaking 
(200 rpm) for 18 h. Bacterial debris was removed by centrifugation for 20 min at 4,500 
rpm. The supernatant was filtered with a filter 0.22 µm pore size and recovered in a 
fresh tube. 250 µl of chloroform were added, and the mix was vortexed. Lysates were 
stored at 4 oC. 
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Bacteriophage stock (Broth) 
 ml 
NB 100 
E50x 2 
Glucose 20% 1 
Bacteriophage  0.1 [109 phages/ml] 
 
 
NB: nutrient broth 
 g/l 
Yeast extract 3 
Peptone  5 
 
 
E 50× 
 g/l 
H3C6H5O7 · H2O 300 
MgSO4 14 
K2HPO4 · 3H2O 1,965 
NaNH4HPO4 · H2O 525 
 
Chemicals were added to 1 l of warm H2O following the order indicated in the table. 
Water was added to reach a total volume of 3 l. The medium was cooled and sterilized 
with chloroform. 
 
Transduction in liquid medium 
 
To carry out transductions in liquid medium, 100 µl of an overnight culture of the 
recipient strain and 10 µl of the donor strain lysate were mixed in a sterile 1.5 ml tube. 
This mix was incubated at 37°C and 200 rpm for 30-45 minutes (depending on the 
marker to be scored). The mix was then spread on selective plates that were incubated at 
37°C until colonies appeared. 
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Detection of lysogenic transductants 
 
Transductant colonies were isolated in EBU plates (with antibiotic if necessary). On 
these plates, pseudolysogens are dark-colored and P22-free colonies are light colored. 
This color difference is due to cell lysis in the pseudolysogenic colony, which causes 
acidification of the medium and turning of the pH indicator, darkening the agar. A 
transductant was considered P22-free when streaking did not give rise to any dark 
colony. 
 
P22 sensitivity assay 
 
In EBU plates, isolates that form light color colonies could be lysogens that do not 
undergo visible lysis. These isolates are P22-resistant and can be mistaken by real P22-
free isolates. To avoid this situation, an assay to detect P22-sensitive strains is 
advisable. A streak with a P22_H5 Lysate is done on an LB or EBU plate, and air-dried. 
The test strain is then streaked in a perpendicular way to the H5 streak. P22-sensitive 
strains grow until they reach the H5 streak, while P22-resistant strains grow over the 
streak. 
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DNA manipulation and transfer 
Plasmids 
Plasmids Characteristics Reference 
pKD46 Lambda Red recombinase, AmpR [297] 
pKD4 Kanamycin resistance gene flanked by FRT 
sites 
[297] 
pCP20 
FLP recombinase, temperature sensitive 
replicon at 37°C,  AmpR, CmR 
[297] 
pET20b 
T7 promoter, AmpR 
 
pET20b-
wbbl 
T7 promoter, AmpR. wbbl gene under 
constitutive expression  
[305] 
pDMS197 Contains lambda pir-dependent R6K 
replication origin; requires lambda pir-
containing bacteria strain. SacB (sucrose 
sensitivity), TcR 
  
[247] 
pDMS197-
wbbl 
TcR. Containing the wbbl gene for 
chromosome integration 
This work 
pXG1 PLtetO promoter , gfp fusion cloning vector [306] 
pXG1::llp Llp gene under constitutive expression  This work 
pIZ2224 pDMS197::PopvAB GATC1,2 [123] 
pIZ2225 pDMS197::PopvAB GATC1,3 [123] 
pIZ2226 pDMS197::PopvAB GATC1,4 [123] 
pIZ2234 pDMS197::PopvAB GATC-less [123] 
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Extraction of plasmid DNA 
For the extraction of plasmid DNA the Gen Elute™ Plasmid Miniprep Kit was used 
(Sigma-Aldrich Co., St. Louis, Missouri, USA). 
 
Extraction of genomic DNA 
For the extraction of genomic DNA, 5 ml of cells were collected from an exponential 
culture and re-suspended in 0.4 ml lysis buffer. Four µl of RNAse (10 mg/ml) were 
added and the mixture was incubated at 37°C for 30 min. After that, 20 µl of proteinase 
K (20 mg/ml) was added and the sample was incubated for 2 h at 65°C. Finally, 3 or 4 
extractions were performed with phenol:chloroform-isoamyl alcohol in a 2:1 
proportion. DNA was precipitated at -20°C by adding 1/10 volume of sodium acetate 3 
M and 2.5 volumes of ethanol. After precipitation, genomic DNA was washed with 
70% ethanol and re-suspended in 20 µl of TER buffer. 
 
Buffer lysis 
 Concentration 
Tris-HCl 50 mM pH 8 
EDTA  10 mM 
NaCl 100 mM 
SDS 0.2 % 
 
TER buffer 
 Concentration 
Tris-HCl 10 mM pH 7.5 
EDTA  1 mM pH 8 
RNAse 20 µl/ml 
 
 
Extraction of bacteriophage DNA  
For the extraction of bacteriophage DNA, the Phage DNA Isolation Kit produced by 
Norgen Biotek Corp. (Schmon Parkway, Thorold, ON, Canada) was used. 
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Digestion, modification and ligation DNA fragments 
Restriction endonucleases were purchased from Roche Diagnostics GmbH 
(Indianapolis, Indiana, USA), New England Biolabs (Beverly, Massachusetts, USA) 
and Promega Biotech (Madison, Wisconsin, USA). 
For ligation of DNA fragments, 1U of T4 DNA ligase (1 U/ml, Roche Diagnostics) was 
used in the buffer supplied by the manufacturer. Routinely, the mixture was incubated at 
16°C for 12 h or at room temperature 24 h. 
For building plasmids with 2 or more inserts, the commercial Gibson Assembly® 
Master Mix was used following the manufacture’s instructions. 
 
Agarose DNA gel electrophoresis 
Electrophoresis in an agarose gel was used to test the quality of DNA extraction, to 
separate DNA fragments after plasmid restriction, to estimate the efficiency of 
endonuclease restriction, to confirm PCR amplification, etc. The agarose gel was 
submerged in TAE 1× buffer. Low electro endosmosis agarose (Pronadisa, Conda, 
Spain) was employed. Its concentration varied between 0.8 and 1.5% depending on the 
size of the fragments to be separated. The loading buffer used was a solution of 
bromophenol blue (0.125%) and Ficoll 400 (12.5%). 
 
The 1 Kb ladder (GIBCO BRL, Life Technologies, New York, USA) was used as 
molecular weight marker. Samples were mixed with 1/10 of loading buffer. SYBR™ 
Safe DNA Gel Stain (Invitrogen) was added to the gels to make bands visible. Gels 
were illuminated and pictures were taken with a ChemiDoc™ (Bio Rad). 
TAE 
 mM 
Tris-acetate 40 mM 
EDTA 10 mM pH 7.7 
 
 
Isolation of DNA fragments from agarose gels 
For the isolation of DNA fragments from agarose gels the commercial system Wizard® 
SV Gel and PCR Clean-Up System was used (Promega Co.). 
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Bacterial transformation 
High efficiency E. coli  transformation 
 
Competent cells were prepared using a variation of the Inoue method (Inoue et al. 
1990), which guarantees high transformation efficiency (5×107 to 5×108 transformants 
per µg of plasmid DNA). An overnight culture of E. coli DH5α was diluted 100-1000 
times in 200 ml of SOB and incubated at 22°C and 200 rpm to reach an OD600 around 
0.5. The culture was then chilled quickly on ice and kept on it for 10 min. Cells were 
harvested by centrifugation at 2,500 g and 4°C for 10 min, the pellet was re-suspended 
in 20 ml of cold TB, and 1.5 ml of DMSO was added. After a 10 min incubation on ice, 
aliquots of 0.2 ml or 0.5 ml were prepared, frozen in liquid nitrogen, and stored at -
80°C. 
For transformation, an aliquot of competent cells was slowly thawed on ice and was 
mixed with the plasmid. The mixture was incubated on ice for 30 min subjected to heat 
shock (42°C, 45 s), and cooled on ice for 1 min. One ml of LB was then added. The 
mixture was incubated at 37°C for 1 h; finally, the cells were concentrated in 100 µl and 
spread on selective media. 
 
TB 
 mM 
PIPES 10 
CaCl2 15 
KCl 250 
pH 6.7  Adjust with KOH 
MnCl2 55 
This solution was sterilized by filtration 
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E. coli and Salmonella electroporation 
 
The method was the same for E. coli and S. enterica: an overnight culture was diluted 
100 times in LB medium and was incubated at 37°C or 30°C depending on the strain to 
reach an optical density of 0.6-0.8 approx. The culture was then incubated in ice for 5 
minutes. Fifty ml were transferred to a new tube, and the cells were harvested by 
centrifugation at 4500 rpm for 10 min at 4°C. The supernatant was discarded, and the 
bacterial pellet was softly re-suspended in 5 ml of cold glycerol 10% prepared in dd 
H2O. Afterwards, 45 ml of cold glycerol were added. A second wash step was repeated 
in the same conditions. Finally, the cells were harvested and re-suspended in 250 µl of 
glycerol 10%.  
 
Electroporation was done by mixing approx. 600 µg of DNA with 60 µl of competent 
cells. The mixture was transferred to a cooled cuvette with a 2 mm distance between 
plates. The mixture was subjected to an electric discharge in the electroporator (2.5 KV, 
200 Ω and 25 µF). The electroporator employed was a BTX Electrocell Manipulator 
600 (Harvard Apparatus, Holliston, Massachusetts, USA). After the discharge, 1 ml of 
LB was added to the cells, which were then transferred to a 10 ml plastic tube and 
incubated at 37°C with shaking (200 rpm) for 1 h. Finally, the cells were concentrated 
in 100 µl and spread on selective media. 
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Construction of bacterial strains 
Oligonucleotides 
 
Name Sequence (5'-3') 
Amplification of the KmR gene from pKD4 
Operonlac-
PS1 
ATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATGTGTAG
GCTGGAGATGCTTC 
Operonlac-
PS2 
TAGGCCTGATAAGCGCAGCGTATCAGGCAATTTTTATAATCATATGA
ATAT 
Amplification of the opvAB operon (wild type and variants) for integration in E. coli 
MG1655-
opvA 
ATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATTCATTT
GGTTATAAATAGAG 
MG1655-
opvB 
TAGGCCTGATAAGCGCAGCGTATCAGGCAATTTTTATAATGAGTTTA
TCTCTGCGCAATGT 
Amplification of gfp and CmR genes from pZEP07 
pCE40lacY-
gfp-5  
GCTTTCCCTGCTGCGTCGTCAGGTGAATGAAGTCGCTTAATAAGAAG
GAGATATACATATGAG 
pCE40-km-3 AAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTTTATCACT
TATTACAGGCGTA 
Amplification of the aac6´1b-cr gene 
opvA-BI-
aac6-F 
TCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGAGCAA
CGCAAAAACAAAG 
opvA-D25-
acc6 
 
TTATGTGTGGGTTTTATCTTATGAAGAAATATACGTTCGCTCG
GGAGGGTTTCTAATGAGCAACGCAAAAACAAA 
 
aac6-gfp-R AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTATTAGGCAT
GACTGCGTGTTC 
Amplification of the blaCTX-M-15 gene 
opvA-ctxm-
F 
TCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGGTTAA
AAAATCACTGCG 
ctxm-gfp-R AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTATTACAAAC
CGTCGGTGACGA 
Amplification of the aac3 gene 
Materials and methods 
 69 
PopvA-BI-
aac3-F 
ATCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGCATA
CGCGGAAGGCAATAAC 
opvA-D25-
acc3 
 
TTATGTGTGGGTTTTATCTTATGAAGAAATATACGTTCGCTCG
GGAGGGTTTCTAATGCATACGCGGAAGGCAATAACGGAGGCG 
 
GFP-aac3-R GAAAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTACTAACC
GGAAGGCTCGCAAG 
Deletion of the lac operon in E. coli MG1655 
Op.lac-PS1 ATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATGTGTAG
GCTGGAGCTGCTTC 
Op.lac-PS2 TAGGCCTGATAAGCGCAGCGTATCAGGCAATTTTTATAATCATATGA
ATATCCTCCTTAG 
Verification of the deletion of the lac operon 
Op.lac-E1 GGCGCAAACTGTTAATGCTG 
Op.lac-E2 CGCAATGACCATTGAACAGG 
Deletion of IS-50 
IS50-PS1 CATGAAGCATGATGATTTGCTGACATATATTAAATATGTCGTGTAGG
CTGGAGCTGCTTC 
IS50-PS2 GATCCTGCGCACCAATCAACAACCGTATCAGAATAGATACCATATG
AATATCCTCCTTAG 
Cloning of the wbbl gene onto plasmid pDMS197 
SacI-wbbl-F AAAGAGCTCATGGTATATATAATAATCGTTTCCCACGGAC 
XbaI-wbbl-
R 
AAATCTAGATTACGGGTGAAAAACTGATGAAATTCGATC 
Verification of wbbl restoration 
Wbbl-E1 ATTCTAATAACGATGACATG 
Wbbl-E2 CGCTGAATGCTCGCGGCCTG 
Assembly of llp into pGX1 plasmid 
pXG1 RBS 
GFP F 
TAAGAAGGAGATATACATATGGCTAGCAAAGGAGAAGAAC 
pXG1- Llp-
R 
ATTTTTTCATGGTACCTTTCTCCTCTTTAATG 
Llp-F GAAAGGTACCATGAAAAAATTATTTTTAGCTATGGC 
Llp-R TGCTAGCCATATGTATATCTCCTTCTTATTAGAAAACTCCCTCGCATG 
Materials and methods 
 70 
Construction of PopvAB::Llp::gfp 
PopvAB-BI-
Llp-F 
 
TTATGTGTGGGTTTTATCTTATGAAGAAATATACGTTCGCTAA
GGAGGTTTTCTAATGAAAAAATTATTTTTAGC 
 
GFP-Llp-R AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTATTAG
AAAACTCCCTCGCATG 
opvAB gfp fusions 
PopvAB-
GFP-F2 
TCTTATGTGTGGGTTTTATCTTATGAAGAAATATACGTTCTAAGAAG
GAGATATACATAT 
STM2208sto
p-GFP-5 
CGCTAACAGAATATCGTATTGAGAAAAAGACAATGAATGACCGCGC
ATGATAAGAAGGAGATATACATATGAG 
STM2208sto
p-GFP-3 
ACTTTTACTCTTCGACACATTTCAGCGCAGAGTTTATCTCTGCGCAAT
GTTTATCACTTATTCAGGCGTA 
Cloning of an amp-sacB counterselection cassette 
opvA-
kansacB F 
TCTTATGTGTGGGTTTTATCTTATGAAGAAATATACGTTCGCTAAGG
AGGTTTTCTAATGTAGGCTGGAGCTGCTTC 
kansacB-
GFP R 
AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTACATATGAA
TATCCTCCTTAGTTCC 
 
Polymerase chain reaction (PCR) 
 
For PCR reactions, a BIO-RAD T100™ Thermal Cycler thermocycler was used. PCR 
reactions were carried out with 1 ng of DNA, 100 µM of dNTPs (final concentration 
each), 1 µM of oligonucleotides, 1 mM of MgCl2, and 1 U of Taq polymerase per 
reaction in a final volume of 100 µl. The polymerase used in these reactions was Taq 
Expand™ High Fidelity PCR System supplied by Roche Diagnostics GmbH. 
To confirm clones and mutations, colony PCR was performed using Go Taq® Flexi 
DNA Polymerase (Promega Co.). In these cases, a mixture with 100 µM of dNTPs each 
one, 0.2 µM of oligonucleotides, 1 mM of MgCl2 as final concentration and 1U of Taq 
polymerase per reaction in a final volume of 25 µl was prepared. A colony was re-
suspended in this mixture and was used as DNA template. 
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Before using a PCR product in further experiments, oligonucleotides and dNTPs were 
removed using the commercial Wizard® SV Gel and PCR Clean-Up System (Promega 
Co). 
 
Chromosomal gene disruption using PCR products 
 
To obtain knockout mutants of chromosomal genes, the Datsenko and Wanner method 
was used [297]. This method is based in the λ Red recombination system. One of the 
reasons why E. coli and Salmonella are not transformable with linear DNA is due to the 
presence of intracellular exonucleases that degrade it. The λ Red system harbors 𝛼, 𝛿 
and exo genes that encode the proteins Gam, Bet and Exo, respectively. Gam inhibits 
host exonuclease V, allowing the Bet and Exo proteins to carry out recombination of the 
DNA. The strategy consists in replacing the chromosomal sequence (Figure M1) by an 
antibiotic resistance marker that is generated by PCR using oligonucleotides that harbor 
40 nucleotides of homology with the sequence to be replaced (H1 and H2 in Figure 
M2). λ Red recombination gene expression is carried out under an inducible promoter 
of thermosensitive low copy number plasmid (pKD46). After selection, the gene 
resistant marker can be removed using a different plasmid (pCP20) that harbors the FLP 
recombinase of the 2 µ plasmid from Saccharomyces cerevisiae. The FLP system acts 
over FRT repeats (“FLP recognition target”) that flank the sequence (Figure M1). 
Plasmids that harbor Red and FLP systems are thermosensitive and can be cured by 
growing the cells at 37°C. 
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Figure M1. Diagram of the inactivation system by PCR. H1 and H2 are DNA sequences 
homologous to the target. P1 and P2 are the homology sequences that flank the antibiotic gene 
sequence. Figure adapted from [297]. 
 
Preparation of DNA for substitution 
 
The plasmids used as templates in PCR reactions were pKD3 (CmR), pKD4 (KmR) and 
pKD13 (KmR). The oligonucleotides used had 40 nucleotides that were homologous to 
the genomic DNA and 20 nucleotides that were homologous to pKD3, pKD4 and 
pKD13 (Table M5). PCR reactions were carried out at an annealing temperature of 
55°C for 2 min. For the DNA fragment extension, the enzyme employed was the Taq 
Expand™ High Fidelity PCR System (Roche Diagnostics GmbH). The PCR product 
obtained was subjected to an agarose gel electrophoresis and the amplified fragment 
was purified using the commercial system Wizard® SV Gel and PCR Clean-Up System 
(Promega Co). 
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Cell transformation 
 
Competent cells of the wild type strain, which harbored the pKD46 plasmid, were 
prepared. This plasmid expresses the λ Red system under the control of the araB 
promoter, which is inducible by arabinose. Cultures grown in LB with ampicillin at 
30°C were diluted 1:100 in LB with ampicillin and arabinose (1 mM) and were 
incubated in a shaker at 30°C until they reached an OD600 of approx. 0.5. Competent 
cells were prepared, and electroporation was done as described previously. 
 
Excision of the resistance marker 
 
After the substitution of genomic genes with antibiotic resistance cassettes (Km or Cm), 
mutations were transferred to appropriate genomic backgrounds by transduction with 
P22 and selection on appropriate media. When necessary, the resistance marker of the 
host was excised by transducing plasmid pCP20 with phage P22 HT. The transduction 
mixture was incubated at 30°C for 1 h and spread on LB with ampicillin. To eliminate 
the plasmid, incubation on EBU plates without antibiotic was performed at 37°C. To 
confirm the excision of the marker, the isolates were streaked on plates of LB ampicillin 
and plates of LB with chloramphenicol or kanamycin. Excision of the antibiotic marker 
was confirmed by colony PCR using external oligonucleotides. 
 
Strain construction by transductional transfer of genetic markers 
 
Genetic markers were transferred from one strain to another by transduction. The 
recipient strain was transduced using a P22 lysate from a strain with the desirable 
genetic marker. All the markers used were selected directly by spreading the 
transduction mixture on selective media. If necessary, acquisition of the marker by the 
transductant was confirmed by PCR or phenotypic analysis. 
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Construction of lac fusions 
 
The method described by Ellermeier et al. was used to construct transcriptional and 
translational fusions (Ellermeier et al. 2002). This method allows the construction of lac 
fusions using the FLP/FRT recombination system. As described previously in the 
method developed by Datsenko and Wanner [297]), a selectable marker (e.g., conferring 
antibiotic resistance) can be inserted at any place in the bacterial chromosome. The 
insertion is flanked by two FRP sites, and the marker can be removed using the plasmid 
pCP20, that harbors the FLP system. As a result of the excision there is one FRT site 
only at the insertion place (Figure M1). This FRT site can be used to insert a plasmid 
that harbors a FRT site upstream of the lacZY genes, yielding a transcriptional or 
translational fusion, depending on the plasmid chosen. Ellermeier et al. constructed 
three different plasmids: pCE36 and pCE37 for transcriptional fusions, and pCE40 for 
translational fusions. Plasmid pCE40 lacks the ribosomal binding site of lacZ and has 
STOP codons in all the frames, except one. These plasmids harbor a Km resistant gene 
and the replication origin of R6K (which is active when the protein 𝜋 is present). 
Choice of plasmid depended on the orientation of the FRT in the original mutation 
(Figure M2). 
 
Figure M2. Diagram of construction of a lac fusion on the chromosome. As an example, 
construction of a translational fusion using the plasmid pCE36 is shown [298]. 
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Calculation of phase variation rates 
Phase variation rates were estimated as described by Eisenstein [307]. Briefly, a strain 
harboring a lacZY fusion was plated on LB+X-gal and colonies displaying an ON or 
OFF phenotype after 16 h growth at 37ºC were selected, resuspended in PBS and re-
spread on fresh LB+X-gal plates. Phase variation frequencies were calculated using the 
formula (M/N)/g where M is the number of cells that underwent phase variation, N the 
total number of cells, and g the total number of generations that gave rise to the colony. 
Flow cytometry 
Bacterial cultures were grown in LB at 37°C until exponential phase (O.D600 ∼0.3). 
Cells were then diluted in PBS to a final concentration of ∼107/ml. Data acquisition and 
analysis were performed using a Cytomics FC500-MPL cytometer (Beckman Coulter, 
Brea, CA, USA). Data were collected for 100,000 events per sample and were analyzed 
with CXP and FlowJo 8.7 software. Data are represented by a dot plot (forward scatter 
[cell size] versus fluorescence intensity). 
Growth curves 
Overnight cultures were diluted into a total volume of 200 µl per well. Plates were 
incubated at 37°C with shaking on an automated microplate reader (Synergy HTX 
Multi-Mode Reader, Biotek) and the absorbance at 600 nm was measured every 30 min 
for each well. The duration of each assay was 20 h. Assays were performed in triplicate. 
In PopvAB::lacZY assays, minimal medium NCE with lactose (0.2%) or glucose (0.2%) 
was used. In the case of antibiotic growth curves LB medium and LB medium with 
antibiotics were used.  
Electrophoretic visualization of LPS profiles 
To investigate LPS profiles, bacterial cultures were grown in LB overnight. Bacterial 
cells were harvested and washed with 0.9% NaCl. The O.D.600 of the washed bacterial 
suspension was measured to calculate cell concentration. A bacterial mass containing 
about 3×108 cells was pelleted by centrifugation. Treatments applied to the bacterial 
pellet, electrophoresis of crude bacterial extracts, and silver staining procedures were 
performed as described by Buendia-Claveria et al. [308]. 
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Phage isolation from water samples 
Samples of water were filtered using a filter Millex-GS 0.22 µm filter pore. Each 
sample was divided into two samples, and chloroform was added to one sample. The 
filtered sample of water (1 ml) was added to an overnight culture of a host bacterial 
strain (0.5 ml). The mixture was supplemented with 3.5 ml of LB and was incubated 
overnight at 37oC without shaking. The culture was then centrifuged at 5,000 rpm 
during 5 minutes. The supernatant was filtered using a 0.22 µm filter in order to save 
only phages. 
A 50 μl aliquot from an overnight culture of the target bacterial strain was spread on LB 
plates, and lysates were dropped onto the surface. The plates were left to dry and were 
inspected for lysis zones after an overnight incubation at 37°C. The spot assay was used 
to assess the bactericidal ability of the phage lysates. Isolation of phage was done by the 
double agar layer method using Salmonella or E. coli as bacterial host. Isolated plaques 
were suspended in LB and were streaked in plates which contained a bacterial layer in 
order to isolate a pure preparation of phage. Phages were characterized on the basis of 
plaque morphology and host range. Moreover, some phage genomes were sequenced 
studied by electron microscopy. 
 
Detection of phage from a crude sample of water 
A tube with 3.5 ml of LB, 0.5 ml of an overnight culture of SV6727 strain (opvAB::gfp) 
and 1 ml of a 0.22 µm filtered water sample was incubated for 7 hours in static 
condition. The culture was diluted at a ratio of 1/200 in LB medium and incubated at 
37°C under shaking (200 rpm) for 3 hours. Samples were diluted in PBS. Data 
acquisition and analysis were performed using a Cytomics FC500-MPL cytometer 
(Beckman Coulter, Brea, CA). Data were collected for 100,000 events per sample and 
analyzed with CXP and FlowJo 8.7 software. The existence of phages in water was 
checked simultaneously by plating 1 ml of water on a plate with S. enterica poured in 
soft-agar. 
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Electron microscopy 
Electron microscopy was performed at the Mediterranean Institute of Microbiology 
(IMM) facility. Phage suspensions (5 µl) were dropped onto a copper grid covered with 
Formvar and carbon and left 3 min. at 25°C, after what the excess of liquid was 
removed. Phage particles were stained according to [154] with a 2% uranyl acetate 
solution. Dried grids were then observed using a transmission microscope FEI Tecnai 
200 kV coupled to a Eagle CCS 2kx2k camera. Images were then analyzed using the 
ImageJ software. 
Bacteriophage detection  
For measurements by flow cytometry, bacterial cultures were grown at 37°C in LB (5 
ml) containing phages (100 µl of phage lysate [108-1010 PFU]). Culture was diluted 
1/100 in LB+phages and was incubated until exponential phase (O.D600 ~0.3) before 
flow cytometry analysis. 
For construction of growth curves, overnight bacterial cultures were diluted 1:100 in 
200µl LB. Five μl of a bacteriophage lysate were added (108-1010 PFU). O.D600 and 
fluorescence intensity were subsequently measured at 30 min intervals using a 
Synergy™ HTX Multi-Mode Microplate Reader from Biotek. 
Epsilometer (E) tests of antibiotic resistance 
Etest strips were purchased from bioMérieux. Mixes of overnight cultures of bacteria 
grown in MH broth were diluted 1:25 in phosphate buffered saline (PBS) to reach cell 
densities of 0.5 MacFarland or about 1.5×108 CFU/ml. Bacteria were plated onto MH 
agar plates using sterile cotton swabs dipped in the cell suspensions, and an Etest strip 
was applied on top. Plates were incubated 18 h at 37°C before reading the results and 
taking pictures. 
Population analysis profile (PAP) tests 
PAP tests were performed on MH agar plates supplemented with increasing amounts of 
kanamycin (Sigma Aldrich) as described elsewhere [309]. Five µl of overnight cultures 
in MH broth (containing approx. 3×109 cells/ml) and serial dilutions (down to 10−6) 
were spread on MH plates containing no antibiotics (for total CFU determination) or 
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different concentrations of kanamycin. The plates were incubated overnight and the 
colonies were counted. Colony numbers were plotted in a graph to determine if the PAP 
fulfilled the criteria for heteroresistance (at least 8-fold difference in antibiotic 
concentration between the highest non-inhibitory concentration and the highest 
inhibitory concentration). 
To prepare mixtures of resistant and susceptible cells, three isolated colonies of SV9776 
(PopvAB::aac3::gfp, kanamycin resistant in the ON state) and SV9777 (PopvAB::gfp, 
kanamycin sensitive) were grown overnight in 2 ml MH broth at 37°C under shaking. 
Pure cultures of each overnight or three independent sets of SV9776:SV9777 mixtures 
at proportions ranging from 1:10 to 1:10,000 were used for PAP tests. 
 
Secuencing of bacteriophage DNA 
Nextera-XT kit from Illumina was used to construct the libraries. The input DNA was 
diluted in water at a final concentration of 0.2 ng/µl, verified by Qubit dsDNA-HS 
assays. A MiSeq v2 flow cell was used to generate pair-end reads (2 x 150 bp). De novo 
assembly was achieved with SPADES using the the FASTQ files generated by the 
MiSeq sequencer. Phage genomes were then annotated with RAST 
(http://rast.theseed.org/FIG/rast.cgi). 
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Bistable expression of lacZY under opvAB transcriptional 
control 
 
The ability of the opvAB epigenetic switch to confer bistable expression to a heterologous 
locus was tested by engineering a strain that harbored the E. coli lacZY operon downstream 
of the opvAB promoter and its upstream regulatory region (Figures  C1.1A and C1.1B). To 
avoid cell-to-cell heterogeneity associated with variations in plasmid copy numbers, the 
construct was engineered in the S. enterica chromosome. Construction involved replacement 
of the opvAB coding region with a promoterless lacZY operon, leaving the opvAB promoter 
and upstream regulatory region intact. The construct harbored the opvA ribosome binding 
site (RBS). Plating of the engineered strain on LB containing X-gal yielded Lac+ (blue) and 
Lac– (white) colonies, thus revealing bistable expression of the heterologous lacZY operon 
(Figure C1.1C). Streaking of either Lac+ or Lac– colonies on X-gal agar yielded a mixture of 
Lac+ and Lac– colonies, thus indicating the occurrence of reversible bistability ("phase 
variation") as previously described for the native opvAB locus [309].  
Calculation of phase variation frequencies indicated a frequency of 1.1 × 10-4 ± 0.3 per cell 
and generation for the OFF®ON transition, and 3.4 ± 0.1 × 10-2 per cell and generation for 
the ON®OFF transition. The 300-fold difference between switching rates was two fold 
lower than in the native opvAB locus (OFF ® ON, 6.1 ± 1.7×10-5; ON ® OFF 3.7 ± 
0.1×10-2; 600-fold difference between switching rates)[115]. Increased size of the LacON 
subpopulation may result from multiple factors including potential differences in mRNA 
stability and codon usage constraints. 
Variants of the opvAB::lacZY construct were engineered to further explore the ability of 
opvAB-driven transcription to confer bistable expression to a heterologous locus. One such 
variant involved the use of a mutant opvAB regulatory region lacking GATC sites 1 and 2 
(GATC1,2), previously shown to increase the size of the OpvABON subopulation[310]. As 
expected, a higher proportion of Lac+ colonies were detected (Figure C1.1C). Another 
variant, used as control, lacked all opvAB GATC sites (GATC-less) and locked lacZY 
transcription in the ON state (Figure C1.1C) as previously described for the native opvAB 
operon [115].  
Variants carrying a green fluorescent protein gene (gfp) downstream of the lacZY operon 
were also engineered, and assessment of subpopulation sizes by flow cytometry confirmed 
that the LacON subpopulation formed by the wild type opvAB switch was smaller than that 
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formed by the GATC1,2 variant (Figure C1.1D). Furthermore, only cells in the 
OpvAB::LacZYON state were detected in the strain that harbored the GATC-less construct, 
and subpopulation formation was abolished as above (Figure C1.1D). 
The ability of the opvAB switch to permit selection of one of the subpopulations was 
examined by testing the ability of strains carrying opvAB::lacZY::gfp and opvAB 
GATC1,2::lacZY::gfp constructs to grow in minimal medium with lactose as sole carbon 
source. As above, a strain carrying the GATC-less opvAB::lacZY::gfp construct was 
included as a control. Assessment of the growth patterns of the strains under study revealed 
that the time required for culture saturation was dependent on the size of the 
OpvAB::LacZYON subpopulation present at the start of the culture (Figure C1.1E). 
Reversibility of the OpvAB::LacZYON state was confirmed by growth on NCE-glucose 
(Figure C1.1F).  
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Figure C1.1. Formation of LacZYOFF and LacZYON subpopulations under opvAB control. A. 
Diagram of the opvAB promoter and regulatory region, with the GATC sites outlined. B. Diagram of the 
wild type opvAB operon and the PopvAB::lacZY construct. C. Colonies formed on LB + X-gal by a S. 
enterica strain carrying the lacZY operon under the control of the wild type opvAB control region 
(SV9700, left), and by S. enterica strains carrying the lacZY operon under the control of mutant opvAB 
control regions (SV9701, PopvAB GATC1,2::lacZY::gfp, center; SV9702, PopvAB GATC-less::lacZY::gfp, 
right). D. Flow cytometry analysis of PopvAB::lacZY expression in strains SV9700, SV9701 and SV9702. 
The sizes of LacZYON subpopulations are indicated. E. Growth of strains SV9700, SV9701 and SV9702 
in NCE-lactose. F. Reversible formation of LacZYOFF and LacZYON subpopulations under opvAB control 
in strain SV9700. 
 
Bistable expression of the chimaeric opvAB::lacZY operon in a 
heterologous host, E. coli 
 
The ability of the opvAB switch to operate in a heterologous host was tested in E. coli. For 
this purpose, the opvAB::lacZY::gfp construct and its GATC1,2 and GATC-less variants were 
introduced into the chromosome of E. coli DR3 (ΔlacZY). Strains carrying the 
opvAB::lacZY::gfp and opvAB GATC1,2::lacZY::gfp constructs (DR22 and DR23, 
respectively) formed Lac+ and Lac– colonies on X-gal agar plates, and the number of Lac+ 
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colonies was higher in the strain carrying the opvAB GATC1,2::lacZY::gfp construct. The 
strain carrying the GATC-less construct (DR24) formed Lac+ colonies only (Figure C1.2A). 
Flow cytometry assessment of gfp expression upon growth in LB confirmed the occurrence 
of subpopulations of LacOFF and LacON cells in the strains carrying the opvAB::lacZY::gfp 
and opvAB GATC1,2::lacZY::gfp constructs but not in the strain carrying the GATC-less 
construct (Figure C1.2B). Altogether, these observations indicated that the opvAB switch is 
functional in E. coli. 
 
Figure C1.2. Formation of LacZYOFF and LacZYON subpopulations under opvAB control in E. coli. 
A. Left: Colonies formed on LB + X-gal by an E. coli strain carrying the lacZY operon under the 
control of the wild type opvAB control region (strain DR22). Center and right: Colonies formed on 
LB + X-gal by E. coli strains carrying the lacZY operon under the control of mutant opvAB control 
regions (DR23 and DR24). B. Flow cytometry analysis of opvAB::lacZY expression in strains DR22, 
DR23 and DR24. The sizes of LacZYON subpopulations are indicated. C. Growth of strains DR22, 
DR23 and DR24 in NCE-lactose.  
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Bistable expression of antibiotic resistance genes under opvAB 
control 
 
An additional test of the ability of the opvAB bistable switch to generate bacterial 
subpopulations was performed by cloning antibiotic resistance genes downstream of the 
opvAB promoter in the S. enterica chromosome. The antibiotic resistance genes chosen for 
these experiments were aac3-Ib (henceforth, aac3) and aac(6’)-Ib-cr (henceforth, aac6), 
which encode aminoglycoside acetyl transferases [311], and blaCTX-M-15 (henceforth, ctxM), 
which encodes an extended-spectrum β-lactamase [312]. In these constructs, the native 
ribosome binding sites were replaced with a stronger RBS, named BI [313] to adjust the 
sensitivity of the switch to a level that could permit unambiguous detection of the antibiotic 
resistance phenotype under study, thus facilitating discrimination between OFF and ON 
cells. Experiments with strains carrying PopvAB::aac6::gfp and PopvAB::ctxM::gfp fusions 
(strains SV9703 and SV9706, respectively) yielded bacterial subpopulations resistant to 
kanamycin and to cefotaxime, respectively (Figure C2.3A). Controls using strains that 
constitutively expressed acc6 and ctxM (SV9705 and SV9707, respectively) showed that the 
concentrations of antibiotics used permitted growth (Figure C2.3A). The wild type strain 
ATCC 14028 failed to grow under such conditions, confirming that the concentrations of 
antibiotics used were bactericidal. 
Flow cytometry analysis confirmed that growth in the presence of kanamycin and 
cefotaxime was a consequence of subpopulation selection (Figure C2.3B), excluding the 
idea that growth might result from selection of mutants present in the inoculum. This 
conclusion was further strengthened by the observation that growth in LB restored the initial 
sizes of ON and OFF subpopulations (Figure C2.3B). 
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Figure C2.1 A. Growth of strains SV9703 (PopvAB::aac6::gfp), SV9705 (PopvAB GATC-less::aac6::gfp) 
SV9706 (PopvAB::ctxM::gfp) and SV9707 (PopvAB GATC-less::ctxM::gfp) in LB and in LB + antibiotic 
(kanamycin and cefotaxime, respectively). B. Left: reversibility of formation of KmS and KmR 
subpopulations under opvAB control. Right: reversibility of formation of CtxMS and CtxMR 
subpopulations.  
 
Use of OpvAB synthetic switches for modulation of 
exponential growth 
 
A strain carrying the construction PopvAB::aac6 showed phase variation as described 
above. In this strain, the opvAB promoter drives the expression of aac6, which encodes 
an aminoglycoside acetyl transferase. Thus, the Aac6ON subpopulation is able to grow in 
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presence of kanamycin. Because mutations in GATC sites of the opvAB promoter alter 
OFF and ON subpopulation sizes, we tested whether strains carrying these mutations 
showed different growth patterns in the presence of kanamycin. Relevant observations 
were as follows: 
(i) A strain carrying the construction PopvAB::aac6 reached a density of 0.6 in LB + 
kanamycin after 524 min, while strains carrying GATC1,3 , GATC4  and GATC1,2,3,4  
mutations reached the same absorbance after 428, 356 and 300 min, respectively. An 
interpretation is that the growth rate is higher when the ON subpopulation is larger. 
Because the conversion rate from the ON state to the OFF state is much higher than the 
conversion ratio from OFF to ON, during growth in the presence of kanamycin most of 
the offspring switch to the OFF state and therefore die by the antibiotic effect. The 
slowdown of growth is thus explained by death of cells in OFF state. In other words, 
growth in the presence of kanamycin is slower or faster depending on the ON 
subpopulation size. 
 
Figure C2.2. Growth of strains SV9703 (PopvAB::BI-acc6::gfp), SV10048 (PopvAB GATC1,3::BI-aac6::gfp) 
SV10049 (PopvAB GATC4::BI-aac6::gfp) and SV9705 (PopvAB GATC-less::acc6::gfp) in LB + kanamycin.  
Time each strain takes to reach an optical density of 0.6 in the presence of kanamycin represented in a bar 
chart.  
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Use of different ribosome binding sites (RBS) to optimize gene 
expression 
 
The opvAB operon in OFF state has a basal expression that is difficult to detect in the 
native opvAB operon (in other words, OFF cells are truly OFF). However, basal 
expression can be detected in other constructs: for instance, when the opvA and opvB 
genes are replaced with other genes such as the aminoglycoside resistance gene aac6 
(Figure C2.3), OFF cells show some degree of kanamycin resistance which may blur 
the difference between OFF and ON cells. This problem was overcome by modification 
of the ribosome binding site. In an initial trial, we cloned the aac6 gene downstream of 
the opvAB promoter, the BI RBS and the first (5') 20 nucleotides of opvA. For 
replacement of the aac6 ribosome binding site, we used information described by 
Mutalik et al. on RBS optimization [313]. Because the BI ribosome binding site is 
strong and the Etest allows to discriminate small differences in antibiotic resistance 
levels, basal expression of aac6 gene in the OFF population was high enough to change 
the resistance level of the OFF subpopulation by increasing its MIC over that of the 
wild type lineage. This construct was therefore useless. 
In order to reduce the translation rate of aac6 RNAm, a second construction was 
designed using a weaker RBS named D25 [314]. Because D25 is not a strong RBS, 
translation is decreased and the basal expression of aac6 in the OFF subpopulation is 
not enough to produce the protein concentrations that permit phenotypic change. The 
adjustment of RNAm translation in order to obtain the desired OFF phenotype 
counteracting the effects of the basal expression of the OFF state might help to adjust 
the phenotype depending on the use. In the tests shown in Figure C2.3, the wild type 
strain ACC14028 showed a MIC about 1.5 μg/ml. The strain carrying the construction 
PopvAB::BI-aac6 showed phase variation where the OFF subpopulation presents a MIC 
up to 8 μg/ml. In the case of PopvAB::D25-aac6, the strain showed two resistance levels, 
confirming the existence of phase variation: an OFF subpopulation with MIC about 1.5 
μg/ml, like in the case of the wild type strain, and an ON subpopulation with a MIC of 
about 16 μg/ml. Note that in a strain carrying the PopvAB::BI-aac6 construct the MIC of 
the ON subpopulation exceeds the upper limit of detection of the Etest.  
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Figure C2.3. A. Diagram of the PopvAB::aac6 construct with RBS variants (BI, D25). B. 
Epsilometer tests (Etests) from a wild type strain and SV9704 (D25) and SV9703 (BI). 
 
Use of the OpvAB synthetic switch in generating antibiotic 
heteroresistance 
 
As a proof of concept, we made a preliminary, reductionist examination of the utility of the 
OpvAB switch to address the study of antibiotic heteroresistance. Specifically, we tested 
whether the OpvAB switch could generate, in a susceptible main population, defined 
subpopulations of cells with increased antibiotic resistance. For this purpose, we used a S. 
enterica strain harboring a PopvAB::BI-aac3::gfp construct (SV9776). Expression of aac3 
(Aac3ON) leads to kanamycin resistance (KmR). The frequency of KmR cells formed by a 
pure culture of SV9776 was 1x10-2 (Figure C2.4A), similar to the frequency of ON cells 
B 
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detected when gfp was cloned behind the opvAB promoter (1.1% and 1.1x10-2, respectively: 
Figure C2.1D). To obtain smaller subpopulation sizes without altering other phenotypic 
traits of the strain, SV9776 was mixed with an isogenic strain that expressed PopvAB::gfp 
(SV9777) and did not produce any KmR resistant subpopulation. Mixtures of cells were 
prepared from overnight cultures in Mueller-Hinton (MH) broth at proportions 1:10, 1:100, 
1:1000, 1:10,000 and 0:1. Population analysis profile (PAP) tests were then performed by 
plating on MH agar containing increasing concentrations of kanamycin. After overnight 
incubation, the number of resistant cells and total number of cells were determined to allow 
calculation of the fraction of resistant cells. The numbers of KmR colonies detected in the 
PAP tests were proportional to the amounts of the Aac3ON subpopulations present in each 
mixture, and ranged from 1x10-2 to 1x10-6 (Figure C2.4A). Epsilometer tests (Etests) further 
confirmed that the size of the KmR subpopulation decreased in a manner proportional to 
dilution (Figure C2.4B). 
 
Figure C2.4. The opvAB epigenetic switch as a tool for the study of antibiotic heteroresistance. A. 
Population analysis profile (PAP) tests of kanamycin resistance in strains SV9776 and SV9777 
(carrying opvAB::BI-acc3::gfp and opvAB::gfp constructs, respectively). The proportions indicated 
are those of the mixtures of SV9776:SV9777. Error bars represent standard deviations of three 
independent mixes. B. Epsilometer tests (Etests) performed on the same mixes of SV9776 and 
SV9777. 
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Design and study of synthetic switches with clinical antibiotics 
 
Aminoglycoside (AG) antibiotics are used to treat many Gram-negative and some 
Gram-positive infections and, importantly, multidrug-resistant tuberculosis. Among 
various bacterial species, resistance to AGs arises through a variety of intrinsic and 
acquired mechanisms [315]. Two new synthetic switches were designed in order to test 
them against different aminoglycosides. The two RBS previously described (BI, D25) 
were cloned upstream of the acc3 gene yielding strains SV9776 and SV9792, 
respectively. The aminoglycosides assayed were kanamycin, streptomycin, gentamicin, 
amikacin, netilmicin and tobramycin. MICs for different strains and antibiotics, shown 
in Table C2.1, reveal the cases in which the OFF subpopulation presents a MIC similar 
to the wild type and the ON subpopulation presents a significant increase in resistance 
to the antibiotic.  
 
 
Table C2.1. Etest values on MH (1:10 dilution) for wild type S.enterica, SV9777, SV9776 and 
SV9792.  
 
Further study was focused on those antibiotics for which an antibiotic resistant 
subpopulation was detected: kanamycin, tobramycin and netilmicin. Initially, the 
resistance to these three antibiotics was monitored by Etests which permitted 
determination of the MIC and detection of the presence of an ON subpopulation more 
resistant to the antibiotic. Additional assays were performed by PAP tests (Figure 
C2.5). 
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Figure C2.5: Population analysis profile (PAP) tests and Etests of kanamycin (A), tobramycin (B) 
and netilmicin (C) resistance in strains SV9776, SV9792 and SV9777 (carrying PopvAB::BI-
acc3::gfp, PopvAB::D25-aac3::gfp constructs and PopvAB::gfp, respectively).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3: Design and optimization of bacterial 
biosensors able to detect bacteriophages in raw 
environmental samples 
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Proof of concept using characterized bacteriophages 
 
Based on results published by Cota and collaborators [114], we foresaw that the opvAB 
phase variation operon could be used as a bacteriophage biosensor. Indeed, the 
OpvABOFF subpopulation was shown to be killed by bacteriophages that belonged to 
different families and used LPS for infection, leading to enrichment of the OpvABON 
subpopulation. This population is insensitive to such infections due to the shortening of 
its LPS by the opvAB gene products. Thus, if an opvAB::gfp fusion was used, 
enrichment of OpvABON cells could be detected by increased fluorescence intensity 
[114]. To start with, we wanted to compare the efficiency of two different methods of 
fluorescence detection, flow cytometry and plate reader monitoring, to detect 3 different 
bacteriophages known to use LPS for infection. As shown in Figure C3.1A, flow 
cytometry turned out to be not only very sensitive but also descriptive of the bacterial 
population with the quantification of its heterogeneity. In contrast, fluorescence 
detection using a plate reader only provided a rough assessment of the population 
structure (Figure C3.1B). On the other hand, fluorescence detection using a plate reader 
does not necessitate a high-cost machine such as a flow cytometer and has the 
advantage to give a measure according to the OD600 of the culture. Our standard 
protocol for phage detection by flow cytometry includes 8 h of incubation to ensure that 
phages kill the vast majority of OpvABOFFcells thus leading to the enrichment in the 
OpvABON population. However, thanks to the sensitivity of this technique, 
measurements can be done earlier than 8 h. As depicted in Figure C3.1C, incubation 
for 1 or 2 h after dilution into fresh medium in the presence of P22_H5 led to 2.6% and 
11.3% of positive cells respectively. Since flow cytometry is highly reproducible, these 
levels are sufficient to discriminate a OpvABON subpopulation from the background 
level of cells that passed the fluorescence threshold in the absence of phage (0.23%) 
(Figure C3.1C). These experiments thus validated the proof-of-concept of a fluorescent 
biosensor for the detection of LPS-using bacteriophages based on a modified version of 
the opvAB operon. 
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Figure C3.1. Detection of the increased of fluorescence intensity when ON-subpopulation is 
selected by bacteriophages. A. GFP fluorescence distribution in a ATCC 14028 derivative strain 
(SV6727) carrying an opvAB::gfp fusion (SV6727) before (t = 0 h) and after growth in LB without 
phage, or in the presence of either P22_H5, 9NA, or Det7 (t = 8 h). Data are represented by a dot 
plot (side scatter versus fluorescence intensity [ON subpopulation size]). All data were collected for 
100,000 events per sample. B. Growth curves of SV6727 strain in contact with P22_H5, Det7 or 
9NA phage. Data are represented by growth curves [GFP fluorescence intensity] versus growth 
[OD600]. C. GFP fluorescence distribution of SV6727 strain before (t = 0 h) and after growth in LB 
containing Det7 (t = 1 h or 2 h). 
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Detection of uncharacterized bacteriophages 
 
To go further with the phage detection tool, we decided to isolate and purify various S. 
enterica-infecting bacteriophages and test whether they could be detected without 
previous characterization of the phage receptor. Indeed, a phage that would need a 
functional and extended LPS should kill the OpvABOFF subpopulation as the known 
phages did. In contrast, S. enterica OpvABOFF cells should resist to the killing by a 
phage that would not need such LPS. Various phages were enriched, isolated and 
partially characterized from different environments in the Seville area as described in 
the Methods section. Without going deeper into the characterization of those phages, the 
plaque morphologies (not shown), and even more the images obtained after negative 
staining by TEM indicated that the 6 isolated phages were different from each other 
(Figure C3.2A). The 6 of them were assayed by flow cytometry for detection using the 
opvAB::gfp fusion. Interestingly, all 6 were perfectly detected 8 hours post-infection 
with more than 60% of the cells in the ON state (Figure C3.2B). This proportion 
reached up to 90% for three individual phages (Se_F1, Se_F6 and Se_AO). In contrast, 
Se_F3 and Se_ML killed the OpvABOFF subpopulation only partially. A conclusion 
from these experiments was that the opvAB::gfp fusion provides an efficient tool to 
detect unknown LPS-using bacteriophages of S. enterica. The variations observed 
between the different flow cytometry profiles could be due to a difference in the usage 
of the LPS as a receptor for those phages as discussed below.  
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Figure C3.2. Detection of new bacteriophages. A. GFP fluorescence distribution in strain SV6727 
(opvAB::gfp) before (t = 0) and after growth in LB containing new purified bacteriophages (Se_F1, 
Se_F2, Se_F3, Se_F6, Se_ML and Se_AO) after 8 h. Data are represented by a dot plot (side scatter 
versus fluorescence intensity [ON subpopulation size]). The percentage of ON cells in each sample 
is indicated. All data were collected for 100,000 events per sample. B. Negative staining of 
bacteriophages visualized by electron microscopy. 
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An especially appealing objective of the present tool is to use opvAB::gfp fusion to 
detect bacteriophages in crude samples and before any enrichment step (in other words, 
before processing). Different crude water samples collected in the Seville area were 
assayed for the presence of phages in the presence of the biosensor strain for 10 h 
before analyzing the resulting populations by flow cytometry. Among the four samples 
tested, three (EM1, EM2 and EM3) displayed a significant increase in GFP activity, 
indicating that indeed these samples contained bacteriophages using LPS for infection 
(Figure C3.3). This conclusion was confirmed by plaque assay (not shown). One 
sample (AO) did not show increase of the OpvABON subpopulation, which suggested 
that the sample did not contain any LPS-using phage active against S. enterica. 
Alternative explanations were that the sample might contain a phage inhibitor or that 
phage present in the sample infected both OpvABON and OpvABOFF S. enterica. 
Taken together these results prove that our opvAB-based fluorescent biosensor can 
efficiently detect the presence of LPS-using bacteriophages in environmental samples 
without any pre-processing other than incubation with the biosensor. 
 
 
Figure C3.3. Detection of bacteriophages from crude water samples. GFP fluorescence 
distribution in SV6727 (opvAB::gfp) before and after growth in LB for 10 hours in the presence of 
crude water previously filtered. Data are represented by a dot plot (side scatter versus fluorescence 
intensity [ON subpopulation size]). The ON subpopulation percentage is shown for each sample. 
Data were collected for 100,000 events per sample. The presence of bacteriophages was previously 
verified by a plaque assay (20-30 PFU /ml) on a S. enterica lawn. 
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Sensitivity of the phage detection tool 
 
To characterize the limits of the phage detection tool, 9NA was used (Figure C3.1). We 
first determined the detection limit in a fluorescence plate reader by using serial 
dilutions of 9NA. As shown in Figure C3.4A, only the most diluted sample, equaling to 
10 PFU/ml, could not be distinguished from the control experiment with no phage. 
Therefore, using a fluorescence plate reader, as little as 100 PFU/ml could be detected. 
Interestingly, the curves obtained in the presence of effective amounts of phage show an 
interesting profile. In the first five hours, the global tendency was an increase of the 
whole population (OpvABON and OpvABOFF), followed by a rapid decrease (Figure 
C3.4A, Inset). Five hours post-infection, the bacterial growth resumed more or less 
rapidly depending on the amount of phage initially present in the culture. As expected, 
the fluorescence intensity correlated with growth only when samples were initially 
infected with 9NA (≥100 PFU/ml) (Figure C3.4A), indicating that only the ON 
subpopulation grew under these conditions. This was confirmed by the fact that the 
highest fluorescence intensity was reached in the presence of the highest amount of 
phage, which killed the OpvABOFF subpopulation more efficiently. As expected, 
without initial phage infection (or with phages ≥ 10 PFU /ml) essentially no increase of 
fluorescent was correlated to bacterial growth, indicating that mainly the OpvABOFF 
population accounts for bacterial growth. Based on this experiment, we tentatively 
concluded that strong, dose-dependent fluorescence intensity was reached 10 hours post 
infection (Figure C3.4A, Inset). In order to test those parameters using flow cytometry, 
the same serial dilutions of phages were applied for 10 h and enrichment of the 
OpvABON subpopulation was monitored. At variance with the plate reader experiment, 
except the 1 PFU/ml, all the phage concentrations tested were able to enrich the ON 
subpopulation (Figure C3.4B). Moreover, above a concentration 102 PFU, a linear 
correlation was observed between the phage concentration and the OpvABON 
subpopulation size, which could be used as a calibration curve to determine phage 
concentration in a given sample. Hence, the phage biosensor appears to be highly 
sensitive and can detect as little as 10 PFU/ml. 
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Figure C3.4. Sensitivity of the OpvAB phage biosensor. A. Growth curves of SV2767 strain 
(opvAB::gfp) in contact with serial dilutions of phage 9NA starting from 106 up to 101 PFU/ml. 
Data are represented by growth curves showing OD600 versus time [hours], and fluorescence 
intensity [ON subpopulation size] versus growth [OD600]. B. GFP fluorescence distribution in 
SV6727 before (t = 0) and after growth (t = 10 h) in LB containing serial dilutions of 9NA 
phage starting from 106 up to 100 PFU/ml. Data are represented by a dot plot (side scatter versus 
fluorescence intensity [ON subpopulation size]). All data were collected for 100,000 events per 
sample.  
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Optimization of the detection tool 
 
Our next objective was to improve the detection limits of our biosensor. As we noticed 
that killing of the OpvABOFF subpopulation (and thus selection of the OpvABON 
subpopulation) was more efficient in the presence of a high number of phages 9NA 
(Figure C3.4A), we aimed at improving the method by adding less cells to increase the 
ratio phage / biosensor. Indeed, the more diluted were the cells, the smaller number of 
phages that could be detected (Figure C3.5A). It is remarkable that for the smallest 
dilution of the overnight culture, the concentration of phages detected using a 
microplate reader was around 4.105 PFU/ml, whereas as little as 4 PFU/ml were 
detected using a higher dilution of the biosensor (equivalent to 8.8×104 cells/ml, 
corresponding to about 17,600 ON cells), thus increasing 5-log the detection limit when 
the number of cells decreased 3-log only.  
Another improvement originated from earlier work showing that opvAB expression 
increased when specific GATC sites present in the promoter region were mutated [114], 
[115]. Indeed, when the opvAB::gfp GATC1,2 construct was used as a biosensor for 
phage 9NA, the fluorescence increased faster than with the construct bearing the wild-
type promoter and reached a plateau in about 10 h (Figure  C3.5B, Inset). Interestingly, 
the largest difference was observed around 7 h post-infection. 
 
We then combined both improvements (low cell density and mutations in GATC sites) 
to reach an even lower detection limit. The experiment described in Figure C3.5C was 
performed in two steps. First, we used as little as eight 9NA phages diluted into 500 ml 
of LB containing a dilution (1/10) from an overnight culture of the biosensor strain and  
let the phage enrichment proceed for 15 h. Then the mixture was diluted again into fresh 
medium to let the OpvABON subpopulation enrich for 5 h before the flow cytometry 
assay. It is remarkable that this extremely small initial number of phages was able to 
enrich the ON subpopulation up to 86.5% under the conditions described (Figure 
C3.5C), thus lowering the detection level to about 1.6 phages per 100 ml. As a 
reminder, before optimization the detection limit with flow cytometry was 1000 
PFU/100 ml. 
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Figure C3.5. Improving the opvAB biosensor sensitivity. 
A. Bacterial dilutions (10-1 up to 2×10-4) where grown in the presence of serial dilutions of 
bacteriophages 9NA stock as indicated. Bacterial growth was monitored according to time in a 
microplate reader and represented schematically. The green wells are fluorescence positive, and red 
wells are fluorescence negative. 
B. Growth curves obtained for a wild type strain carrying the classical gfp fusion (SV6727) in the 
absence of phage (green), or in the presence of 9NA phage (blue), and for a derivative strain 
carrying point mutations in the first and second GATC sites located in the opvAB promoter 
(SV8578) in the presence of 9NA phage (red). Fluorescence intensity data obtained at several time 
points of the growth curve (inclusion). 
C. GFP fluorescence distribution in SV8578 (opvAB::gfp GATC1,2) before (t = 0 h) and after growth 
in LB containing 9NA phage (t = 20 h). Data are represented by a dot plot (side scatter versus 
fluorescence intensity [ON subpopulation size]). All data were collected for 100,000 events per 
sample.  
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Design of a biosensor able to detect coliphages  
 
Up to this point, the design and improvement of the phage biodetection method was 
performed using S. enterica as a chassis. To widen our capacity to detect phages in 
environmental samples, we decided to adapt the biosensor to coliphages. To do so, we 
first had to restore a full length LPS as E. coli K12 MG1655 is well-known to carry an 
IS5-interrupted version of the wbbL gene encoding a rhamnosyltranferase [305]. This is 
clearly evidenced by the length and profile of the LPS following extraction, separation 
by SDS-PAGE and silver staining is affected in MG1655 (Figure C3.6A, lane 1). The 
interrupted wbbL gene was complemented either by adding a plasmid-based copy of 
wbbL or by integrating ectopically a single copy of the wild type gene. In both cases, 
the LPS was restored and showed a more complex profile (Figure  C3.6A, lanes 4 and 
5). Engineering of strains carrying a opvAB::gfp fusion on the chromosome allowed us 
to examine the consequences of opvAB expression in E.coli. A wild type opvAB control 
region caused a subtle alteration of the LPS profile, an observation consistent with the 
small size of the ON subpopulation (Figure C3.6A, lane 6). Modification of the length 
distribution of glycan chains in the O-antigen was however unambiguous when the 
LPS+ E.coli strain harbored a GATC-less opvAB::gfp fusion (Figure C3.6A, lanes 6 
and 7).  
Using the opvAB::gfp-carrying LPS+ E. coli strain, we isolated and purified 7 
coliphages from water samples from the Seville area. As shown in Figure C3.6B, seven 
of the coliphages were able to select the OpvABON subpopulation with an enrichment 
efficacy ranging from 11.2 to 58.6%, far higher than the control without phage (1.27 
%). Again, this difference could substantiate the use of the LPS as a primary receptor or 
as a full receptor for the isolated coliphages except for Ec_unk_PO1 whose profile does 
not distinguish from the negative control. 
Whatever the case, this experiment shows that the method works alike in E. coli as in S. 
enterica and that the opvAB::gfp fusion is a versatile tool that could be used with 
different enterobacterial chassis. 
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Figure C3.6. Restoration of E. coli MG1655 O-Antigen and detection of unknown coliphages. 
A. Electrophoretic visualization of LPS profiles from different MG1655 derivatives, as follows:  
1. Wild type E. coli MG1655 strain containing an IS5-inactivated version of the wbbl gene; 2. E. coli 
MG1655 with a deletion of the lactose operon (DR3); 3. E. coli DR3 strain carrying the empty pETb 
vector; 4. E. coli DR3 strain carrying the pETb vector containing a copy of the wild type wbbL gene; 
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5. E. coli E. coli DR3 strain carrying the wbbL gene integrated into the genome replacing the altered 
IS5-wbbl gene (LPS+ strain); 6. E. coli MG1655 LPS+ carrying the opvAB construction (DR29 
strain); 7. E. coli MG1655 LPS+ opvAB GATC-less (DR30).  
B. GFP fluorescence distribution in E. coli DR29 derivative before (t = 0 h) and after growth in LB, 
or LB containing purified uncharacterized bacteriophages (Ec_Unk_EM1, Ec_Unk_EM2, 
Ec_Unk_EM3, Ec_Unk_AO1, Ec_Unk_ML, Ec_Unk_ML1 and Ec_Unk_MLB (t = 8 h). Data are 
represented by a dot plot (side scatter versus fluorescence intensity [ON subpopulation size]). ON 
subpopulation percentage frequency is showed for each sample. All data were collected for 100,000 
events per sample.  
 
Expanding the opvAB::gfp biosensor to the detection of 
phages using proteins as receptors: Bacteriophage T5 
detection as a proof of concept  
 
As we have seen that coliphage detection could show high variation (Figure C3.6B), 
probably depending on the receptor molecule used for recognition at the surface of the 
bacteria, we decided to design an E. coli biosensor that would specifically detect a 
phage known to bind a protein. Phage T5 is an appropriate model: although it uses LPS 
for initial adsorption, binding to the ferrichrome transporter FhuA on the outer 
membrane constitutes the trigger for DNA injection [316], [317]. We first thought to 
make a simple PopvAB::fhuA::gfp fusion, but that would have provided us with a 
biosensor working the opposite way from the opvAB::gfp biosensor. Indeed, in this case 
the presence of T5 would select for the OFF (non-fluorescent) subpopulation, and it 
would mean we should be able to detect a slight decrease in fluorescence, which can be 
expected to be less reliable than monitoring an increase of fluorescence intensity. We 
thus looked for a gene which under the control of the opvAB promoter would confer 
resistance to T5 in the ON state. Interestingly, T5 encodes a lipoprotein, encoded by the 
llp gene, which is an inhibitor of T5 infection [318]. Llp is synthesized upon T5 
infection and prevents superinfection of the host by other T5 virions by interacting with 
the FhuA receptor, resulting in its inactivation [319]. Moreover, the llp phage gene is 
expressed in the early stage of T5 infection, which not only prevents superinfection but 
also protects progeny phages from being inactivated by the receptor present in envelope 
fragments of lysed host cells [209]. We thus reasoned that placing the llp gene under the 
control of the opvAB promoter might confer resistance to T5 only on the ON state. As 
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expected from the literature, a DfhuA strain proved resistant to T5, but not to T4, which 
uses OmpC as receptor [320] (Figure C3.7A). In turn, ectopic expression of llp from a 
plasmid also confers resistance to the E. coli MG1655 WT strain as in the DfhuA 
mutant. We thus integrated a PopvAB::llp::gfp fusion at the lac locus in E. coli MG1655 
and assayed this new biosensor with T5 for 10 hours on a plate reader, periodically 
monitoring the OD600 and the florescence intensity (Figure C3.7B). As predicted, 
enrichment of the ON subpopulation was detected after a few (4) hours as GFP 
fluorescence intensity increased on a growth-dependent manner, indicating that this 
fusion performed well as a T5 biosensor. We then assayed the biosensor using flow 
cytometry to estimate the efficiency of ON subpopulation enrichment, which ranged 
from 82% to almost 90% in 10 h for 4 different phages (Figure C3.7C). Interestingly, 
addition of colicin M led to a similar enrichment of the ON subpopulation, thus 
confirming that production of the FhuA inhibitor Llp was also able to prevent colicin M 
binding. We also performed an additional control, using one of the LPS-binding phages 
assayed in Figure C3.6. As predicted based on its effect on the Ec_opvAB::gfp 
biosensor, this specific phage (Ec_unk_EM1) was unable to select for the 
PopvAB::llp::gfp ON subpopulation (Figure C3.7C). Conversely, the Ec_unk_PO1, 
selected to turn on PopvAB::llp::gfp fusion, and thus likely recognizing FhuA, was not 
detected using the Ec_opvAB::gfp biosensor (Figure C3.6C). Together, these 
experiments show that the method can accommodate not only different bacterial chassis 
(Salmonella and E. coli) but also different types of receptors, thus providing a primary 
indication on the type of receptor used by a given phage.  
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Figure C3.7. Bacteriophage T5 detection. 
A. Left. Bacterial growth curves in the presence of phage T5 (2.5 x 107). In blue, E. coli MG1655 
wild type. In red, a strain with a deletion of the fhuA gene (DR42). In green, E. coli carrying an 
empty pXG1 plasmid, used as a control. In purple, E. coli carrying plasmid pXG1 containing the llp 
gene from T5 phage. Right. Plaque assay using the same strains and bacteriophages T5 and T4. 
B. Growth curves of an E. coli derivative strain DR41 carrying a PopvAB::llp::gfp fusion in the 
presence or absence of T5 for 10 hours. Inlet, the same data are represented as a function of time. C. 
GFP fluorescence distribution in DR41 (PopvAB::llp::gfp) fusion before (t = 0. h) and after growth in 
LB containing T5, unknown E. coli phages (Ec_Unk_PO1, Ec_Unk_PO2, Ec_Unk_PO3 isolated on 
E. coli MG1655, and Ec_Unk_EM1 isolated on DR28), or colicin M (3 µg/ml) (t = 8 h). Data are 
represented by a dot plot (side scatter versus fluorescence intensity [ON subpopulation size]). All 
data were collected for 100,000 events per sample.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4: Detection of Dam methylation inhibition 
using an OpvAB-bases biosensor 
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The ability of an opvAB-derived biosensor to detect inhibitors of DNA methylation was 
tested using strain SV9700 (PopvAB::lacZY::gfp). The DNA methylation inhibitor chosen 
for the trial was sinefungin, a natural nucleoside related to S-adenosyl-methionine. 
Sinefungin blocks base methylation in DNA and RNA upon competition with SAM 
[321], [322]. Analysis of bacterial cell viability in the presence of sinefungin revealed 
toxicity above a final concentration of 2.2 mg/ml. Based on this observation, the final 
concentration chosen for the inhibition trial was 1 mg/ml. The fluorescence intensity 
was quantified by flow cytometry. Growth of strain SV9700 in presence of sinefungin 
was accompanied by an increase of fluorescence intensity. An interesting observation 
was that the fluorescence pattern was very similar to that of a dam mutant strain 
carrying the same construction (Figure C4.1). 
Fluorescence intensity and growth were also monitored using a Synergy HTX 
microplate reader. The O.D600 of the culture was monitored to confirm that the 
concentration of sinefungin used in the experiment (1 mg/ml) did not inhibit growth. 
The curves showed differences in the presence and in the absence of sinefungin, thus 
confirming that sinefungin inhibits Dam methylation in S. enterica. Hence, the opvAB-
based fluorescence biosensor appears to be appropriate to detect DNA methylation 
inhibition.  
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Figure C4.1. Detection of Sinefungin. A. Fluorescence intensity of the PopvAB::lacZY::gfp fusion of 
strain SV9700 without sinefungin (blue) and with 1 mg/ml sinefungin (orange). In the right panel, the 
fluorescence intensity was plotted vs culture density. Fluorescence in the presence of sinefungin is similar 
to that of a dam mutant (grey). Fluorescence did not increase at late growth stages, probably due to 
exhaustion. B. GFP fluorescence distribution in SV9700 (PopvAB::lacZY::gfp) in presence or in absence of 
Sinefungin (1 mg/ml) after 5 h. Data are represented by a dot plot (side scatter versus fluorescence 
intensity [ON subpopulation size]). All data were collected for 100,000 events per sample.  
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The work described in this Thesis is based on previous studies of the phase-variable opvAB 
operon of Salmonella enterica, and has used the information provided in those studies to 
design and develop the construction of several types of microbial biosensors able to detect 
environmental signals: antibiotics, phages and DNA methylation inhibitors. Such sensors 
may be considered a novel type of sensor that operates at the population level, unlike 
traditional gene circuits and whole cell sensors.  
In its native host, the opvAB operon undergoes bistable transcription, which generates 
OpvABON and OpvABOFF subpopulations [115]. Bistability is reversible ("phase-variable") 
and the switching rate is skewed to OFF in the wild type [114], [115]. In this study, we show 
that a 689 bp DNA fragment containing the opvAB promoter and the opvAB upstream 
activating sequence (UAS) confers bistability to genes cloned downstream. For instance, an 
engineered PopvAB::lacZY operon produces LacOFF and LacON subpopulations (Figure 
C1.1C), and addition of a gfp reporter gene permits discrimination of LacOFF and LacON cells 
by flow cytometry (Figure C1.1D). Utilization of L-lactose sustains growth of LacON cells 
(Figure C1.1E), thus producing increased fluorescence. However, because the opvAB 
switch is reversible, if a culture grown on L-lactose is transferred to lactose-free medium the 
system slowly returns to its initial state, with strong predominance of LacOFF cells (Figure 
C1.1F). The fact that the opvAB switch is functional in a heterologous host which is also a 
model organism, E. coli (Figure C1.2), might increase its potential interest for synthetic 
biology. The fact that the switching frequencies are slightly different in Salmonella and E. 
coli admits several tentative explanations and can be considered irrelevant for practical 
purposes. as phase variation is unambiguous in both hosts. 
The versatility of the opvAB switch is illustrated by an additional example of subpopulation 
formation presented in Figure C2.1: opvAB-driven bistable expression of kanamycin and 
cefotaxime resistance genes permitted selection of antibiotic-resistant subpopulations in a 
reversible fashion. 
Introduction of mutations in the upstream regulatory region of the native opvAB operon 
alters the switching rate, yielding OpvABON and OpvABOFF subpopulation sizes different 
from those of the wild type [114], [123]. Hence, variants of the opvAB switch can be 
engineered to modulate subpopulation sizes at will. For instance, a variant (GATC1,2) that 
lacks two of the four GATC sites present in the wild type increases the initial size of the ON 
subpopulation (Figures C2.1 and C2.2). Additional UAS variants that yield subpopulations 
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of different sizes have been described [123], and their use may allow choice of other 
switching frequencies. Modification of the ribosome-binding site of gene(s) under PopvAB 
control can also contribute to adjust the sensitivity of the switch, thus facilitating detection 
of the phenotype under study. For instance, use of the D25 ribosome binding site (SV9704, 
SV9792) permitted unambiguous detection of aac3-mediated kanamycin resistance, thereby 
facilitating discrimination of KmR cells (Figure C2.4).                                          
As a proof of concept, we have used the opvAB switch to produce antibiotic-resistant and 
antibiotic-susceptible bacterial subpopulations of predetermined sizes. The aim of these 
experiments was to mimic bacterial heteroresistance to antibiotics under laboratory 
conditions, a phenotype where subpopulations of cells with higher antibiotic resistance than 
the main population are present [323]. Heteroresistance is difficult to detect and study in 
clinical samples [323], and a better understanding of the frequencies of subpopulation 
formation and of their antibiotic resistance levels may improve our understanding of 
heteroresistance as a cause of clinical treatment failure [309]. Experiments shown in Figure 
C2.4 provide evidence that subpopulation formation under opvAB control allows accurate 
modulation of the number of resistant cells present in a population. In principle, the method 
should be applicable to any antibiotic resistance gene. This approach provides a proof of 
concept to study the effect that different frequencies and levels of resistance of resistant 
subpopulations may have on the outcome of antimicrobial treatment in vivo (e. g., in a 
murine model). A relevant advantage of the opvAB switch to be used in vivo is that it can be 
expected to be largely unaffected by infection bottlenecks that could eliminate very small 
subpopulations of resistant bacteria present in the inoculum [324]. Because of this potential 
advantage, the opvAB switch is currently being used at the D. I. Andersson's lab in Uppsala 
University to study antibiotic heteroresistance. 
An additional application of the opvAB switch is the design of sensors able to detect 
bacteriophages in environmental samples. The challenge of accurately count bacteriophage 
has been around for some time as more and more researchers were interested in counting, 
discriminating and characterizing bacteriophages in various environments for ecological or 
biotechnological purposes. Besides the gold standard plaque assay method a variety of 
techniques, each one with pros and cons, have been developed and compared These 
techniques are based on different methodologies such as quantitative PCR (ddPCR or 
regular qPCR), FISH, electronic microscopy, and flow cytometry that can be classified into 
three types: culture-dependent, sequence-based, and particle-based [325]. Another way to 
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classify these techniques is to consider the characteristics of the enumeration and the 
additional infection parameters that can be obtained [326]. For example, the classical plaque 
assay can discriminate infectious versus non-infectious particles, provides information on 
the adsorption rate, is feasible without any particular equipment and does not need genome 
sequencing. A limitation, however, is that the assay is difficult to perform in a high-
throughput manner. On the other hand, a ddPCR-based method is sequence-based and 
therefore necessitates the determination of the phage genome sequence. The method requires 
a specialized equipment, which allows high-throughput analysis. The information provided 
by ddPCR is also different: there is no possibility to discriminate infectious versus non-
infectious particles but the method can discern between different phages in a single assay 
[327]. In the spectra of current methods, flow cytometry-based approaches are among the 
most sensitive and most published methods. Such procedures rely on the labelling of the 
phage genome by a fluorescent dye [328]–[330], although some label-free protocols have 
been developed recently [331]. In this work, we combine culture-based methods with flow 
cytometry, which allows to quantify with high sensitivity infectious particles only (Figure 
C3.5). Cloning of a gfp gene dowstream of the opvAB operon provides a simple an efficient 
sensor to monitor the increase of the OpvABON subpopulation by flow cytometry. This 
increase provides indirect evidence that the OpvABOFF subpopulation undergoes lysis, which 
in turn indicates the presence of a phage that uses the O-antigen as receptor. An advantage 
of this type of sensor is that lysis of OpvABOFF cells and concomitant increase of OpvABON 
cells produce amplification of the signal over time. This feature makes the sensor highly 
sensitive: 109 phages/ml can be detected in 1 h, and an amount of phage as low as 2 PFU in 
100 ml can be detected in 20 h. 
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Figure D1. Diagram for the selection of the OpvABON subpopulation in presence of a bacteriophage 
that uses the O-antigen as receptor. OpvABOFF cells are represented in yellow, and OpvABON cells are 
represented in green. Fluorescence intensity in culture increase in the presence of bacteriophages due to 
an increased of the number of OpvABON cells. 
 
While the original biosensor constructed in S. enterica (Figures C3.1 and C3.2) proved 
able to detect purified or unpurified phages present in raw water samples (Figure C3.3), 
we expanded our collection of biosensors to detect coliphages. Therefore, after 
reconstruction of the MG1655 strain with a complete LPS, the integration at the lac 
locus of an opvAB::gfp fusion under a constitutively active promoter (OpvABON) 
confers a LPS enriched with a short length fraction to E. coli compared to the LPS+ 
strain (Figure C3.6). This observation indicates that in the absence of any identified 
homologs, the OpvA and OpvB proteins are able to generate short-length LPS in E. 
coli. As a result, the E. coli strain generated that way was able to detect LPS binding 
phages in a way similar to the S. enterica strain (Figures. C3.2, C3.6). 
Of note, the enrichment of the OpvABON subpopulation by killing of the OFF 
subpopulation was not as effective with the coliphages we isolated as for the phages 
active against S. enterica. Nevertheless, as the detection by flow cytometry is very 
sensitive and reproducible, the enrichment levels achieved were sufficient for a proper 
detection although maybe not as sensitive. This result may indicate the coliphages we 
isolated required an additional component of the outer membrane as a receptor, 
rendering LPS binding less crucial for a successful infection. This hypothesis is 
strengthened by the fact that in the case of the FhuA binding phages detected using the 
PopvAB::llp::gfp biosensor the enrichment of the ON subpopulation was much more 
efficient (Figure C3.7). Indeed, it is known that T5 relies essentially on FhuA for a 
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productive lytic cycle, whereas the polymannose decoration of the O-antigen is used as 
a primary receptor important for an efficient primary binding but dispensable for the 
overall cycle (Figure C3.7) [332], [333].  
Prior to use of Llp lipoprotein, we used the membrane protein phage receptor FhuA. In 
this case, however, OpvABON cells express the phage receptor in their outer membrane 
with consequent lysis by the phage. Phage detection thus involves a decrease in GFP 
fluorescence, which is a signal less reliable and less unequivocal than fluorescence 
increase. Hence, our second choice was a gene whose expression confers resistance 
instead of sensitivity (e. g., the llp gene in the case of phages that use the Fhua protein 
as a receptor, Figure C3.7). However, the possibility of designing sensors in which the 
meaningful, "positive" signal is fluorescence decrease remains open. 
 
 
 
Figure D2: Selection of OpvABOFF and OpvABON subpopulations in the presence of a bacteriophage 
that uses a heterologous receptor expressed under opvAB control. A. Cells producing FhuA are lysed 
by phage, thus selecting the OpvABON subpopulation and producing a concomitant fluorescence decrease. 
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OpvABOFF cells are represented in yellow, and OpvABON cells are represented in green. B. Cells 
producing Llp are resistant to bacteriophage, and lysis of OpvABOFF cells results in fluorescence increase 
due to growth of OpvABON cells (green).  
 
An important add-on value of our method is its capacity to discriminate between 
bacteriophages infecting the same host but using different types of receptors (Figures 
C3.6, C3.7). This property is highly relevant in the frame of phage therapy when the 
isolation of phages using different receptors is a must to overcome resistance due to 
mutations into the receptor [334]. This work, allowing a rapid discrimination between 
phages using LPS or FhuA as receptors, could thus be systematically used prior the 
assembly of phage cocktails. Moreover, this method could be implemented to other 
receptors used by bacteriophages as long as a specific inhibitor such as Llp is available 
as described for FhuA-binding phage (Figure C3.7). For T-even coliphages, for 
example, the trick would be to use the outer-membrane protein TraT, encoded by the F 
plasmid, that masks or modifies the conformation of outer-membrane protein A 
(OmpA), which is the the receptor for many T-even-like phages [335]–[337]. In case an 
inhibitor-encoding gene does not exist for a dedicated receptor, an alternative would be 
to use the receptor gene itself fused to the gfp and controlled by the opvAB promoter. 
However, in such a case the biosensor will be much less sensitive for phage numeration 
as a decrease in fluorescence is expected. Nevertheless, such an alternative should be 
sensitive enough to determine the host receptor of the phage under study. 
Phage receptor determination is a must to achieve a complete characterization of 
bacteriophages [335]. The canonical method using plaque assay is of course still 
relevant, however it cannot be performed in a high throughput manner. A possible way 
to implement a fast and easy host-receptor determination would be to construct a 
biosensor strain carrying multiple fusions with various fluorescent protein encoding 
genes allowing to detect different phages in a mixture according to their receptor 
specificity.  
Another application of the OpvAB switch described in this Thesis involves the 
detection of DNA methylation inhibitors. Lack of Dam methylation causes strong 
attenuation in Salmonella enterica and in other gamma- and alpha-bacterial pathogens 
[241], [244]. In turn, CcrM methylation has been shown to play roles in the interaction 
of alpha-proteobacterial pathogens with their hosts. These observations has raised the 
possibility of using Dam or CcrM methylase inhibitors as antibacterial drugs [245], 
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[246]. In alpha-proteobacteria, such drugs would be bactericidal. In Salmonella and 
other pathogens in which Dam methylation is not essential, Dam inhibitors could be 
expected to attenuate virulence by transforming wild-type bacteria into phenocopies of 
dam mutants. Because Dam methylation is a dispensable function in enteric bacteria, 
inhibitors specifically targeted at Dam methylase should be harmless for the normal 
intestinal flora. A drug of this kind should be also harmless for the host, because 
adenine methylation is rare in mammalian cells [338]. The potential problem that a Dam 
inhibitor might increase the spontaneous mutation rate in the intestinal flora seems 
minor compared with its potential benefits as an alternative to current antibiotics. 
As a proof of concept, we show that a opvAB:gfp fusion permits dose-dependent 
detection of sinefungin, a well known inhibitor of DNA methylation. Previous searches 
for novel compounds of this kind have been improductive, and one likely reason is that 
the screens employed were not sensitive enough. This Thesis may contribute to 
overcome this problem as a highly sensitive screen can now be devised using the 
OpvAB switch. 
Phase variation-based biosensors can have advantages over classical whole-cell sensors 
based on transcriptional regulators and/or inducible promoters [339], [340]. One 
advantage is that the sensors can be expected to be highly selective as selection of one 
of the subpopulations will occur under specific circumstances only. Use of fluorescence 
to monitor growth cells can be expected to be sensitive and highly reproducible. 
Furthermore, programmed switching from OFF to ON and vice versa may contribute to 
robustness, avoiding the problem of instability frequently found in transcription-based 
gene circuits [341]. 
Besides biosensor design, formation of phenotypic subpopulations under epigenetic 
control may have additional applications in synthetic biology: for instance, division in 
labour between subpopulations performing distinct segments of a catabolic pathway 
might optimize biodegradation processes [342]. 
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1. A 689 bp fragment containing the Salmonella enterica opvAB promoter and upstream 
regulatory region is able to drive transcription of heterologous genes cloned 
downstream of the promoter. 
 
2. Transcription of heterologous genes under opvAB control shows reversible bistability 
(phase variation), giving rise to bacterial subpopulations that differ in the expression of 
the cloned gene or operon. 
 
3. Reversible bistability under opvAB control is reproducible in Escherichia coli. 
 
4. Modification of the ribosome binding site of a gene or operon under opvAB control 
can adjust opvAB expression to a level appropriate to discriminate OFF and ON 
subpopulations. 
 
5. The opvAB epigenetic switch has been used to engineer biological sensors that detect 
subpopulations of bacteria with specific phenotypes (e. g., utilization of lactose and 
resistance to antibiotics). 
 
6. Biosensors based on the opvAB switch permit the detection of bacteriophages and of 
DNA methylation inhibitors. 
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